BONE HEALTH:
The Taiwanese Osteoporosis Association said 8.1 percent of people aged 50 or older experience osteoporosis, but the prevalence among women is higher at 10 percent

  • By Lee I-chia / Staff reporter

Many elderly people aged 65 years or older might experience hip fractures when they fall down, but getting surgery would not be enough to fully recover, and postoperative rehabilitation is crucial for standing up again, the Taiwanese Osteoporosis Association (TOA) said yesterday.

The TOA yesterday held the Fragility Fracture Network (FFN) Taiwan founding conference in Taipei, where TOA chairperson and Kaohsiung Municipal Da-Tung Hospital orthopedist Chen Chung-hwan (陳崇桓) was named adjunct chairperson of the network.

The FFN addresses the full pathway of care for fragility fracture patients, and has been promoting improvements across four main pillars of care that include perioperative care, surgical treatment, rehabilitation, secondary prevention and policy change, the association said, adding that it has expanded its congress in different regions worldwide with participants from 102 countries.

Photo: Lin Liang-che, Taipei Times

Chen said the FFN Taiwan consists of orthopedists, geriatricians, rehabilitation physicians, nurses, physical therapists, occupational therapists, nutritionists and other healthcare professionals, and it aims to integrate resources for maximizing effectiveness in improving the quality of fragility fracture treatment in Taiwan.

According to the National Health Promotion Administration’s national nutrition survey between 2017 and 2020, the prevalence of osteoporosis among adults aged 50 or older was 8.1 percent, but the prevalence among women was higher — about 10 percent were estimated to have osteoporosis.

Chen said most hip fractures occur in elderly people and are caused by falling, and as women have higher rates of weakened bones by osteoporosis and weaker muscle strength, they have a higher risk of getting a hip fracture from a fall than men.

However, the postoperative healthcare they receive is crucial for recovery, as many who return home only to lay in bed, instead of undergoing physical rehabilitation, would have poor outcomes of rapid muscle loss and the inability to stand up and walk, becoming long-term bedridden patients, he said.

West Garden Hospital rehabilitation physician Hsu Po-cheng (徐伯誠) said about half of hip fracture patients need assistive devices or other people’s help to stand up after surgery, and about 90 percent need assistance to climb stairs, so many might lose their mobility to enjoy a full and active life.

However, if people do not practice moving around after the surgery, they could lose bone mass and muscle strength rapidly within a few months, he said, adding that therefore, they should try to leave their bed as soon as possible and get physical rehabilitation to gradually recover to preoperative conditions.

As people would need to add different exercises into their rehabilitation routine depending on their preoperative exercise habits, health conditions, complications and medications, customized plans and supervision might need a medical team with different health professionals, Hsu said.

Chen said the National Health Insurance policy says that large hospitals are responsible for acute treatment, but patients must be transferred to local hospitals or facilities for post-acute care.

Therefore, the FFN Taiwan would launch a hip fracture registry program with a hospitals this year, he said.

The FFN is to collect data from people to better understand what can be improved in the nation’s fragility fracture healthcare system, and try to obtain more resources to improve it, Chen added.

Additional reporting by CNA

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

Source link

With their smushed-in faces and button noses, French bulldogs, pugs and bulldogs are among the most popular breeds in the U.S. But their stout stature has a dark side: the breeds are prone to health problems, particularly with their breathing.

Now, New Hampshire could become the first state in the country to limit the breeding of those dogs. Lawmakers will vote this week on a bill that would prohibit breeding dogs that have a physical trait, like being short-nosed, that "causes suffering."

Bulldogs and other flat-faced breeds can have loud, labored breathing, stemming from brachycephalic obstructive airway syndrome. The dogs have been bred to have shortened skulls, but they still have large amounts of skin and soft tissue, including in their mouths. That obstructs their breathing, particularly putting them at risk of heat stroke, since dogs must pant to cool down.

"A lot of people will see how cute they are on social media," says Ellen Read, a New Hampshire representative who introduced the legislation. "People will buy these very cute, very flat-faced puppies from reputable breeders. You think they're healthy and then come to find out that the animal needs surgery just so it can breathe."

Supporters of the legislation say it's about ensuring the best quality of life for the dogs and protecting dog owners from unknowingly getting dogs that need medical treatment costing thousands of dollars. While the bill is the first of its kind for a U.S. state, countries like Norway and the Netherlands have already taken steps to put breeding restrictions on "breathing-impaired breeds."

Read says the legislation is still being debated, but she supports a version of the bill that would require breeders to have their dogs checked for breathing problems by a veterinarian before they breed them. Knowingly breeding French bulldogs, pugs and bulldogs with serious breathing issues would be a civil penalty, potentially involving a fine.

"The bill isn't taking anyone's dog away," Read says "It's not getting rid of certain breeds. What it's doing is ensuring that the breeding practices are done ethically. And so this bill prohibits, quite simply, breeding two individual animals that have identical deformities that cause suffering."

Opposition to the legislation has been strong from purebred dog groups, including the American Kennel Club.

"Bills like this put our breeders in a defensive posture," says Phil Guidry, director of policy analysis for the American Kennel Club. "This is absolutely extremist. Why go down this road of extremism when we can take the opportunity to honor that common ground and work together in a way that we all agree is a best next step for dogs?"

Guidry says his group supports educating breeders about best practices, instead of imposing penalties that target specific breeds. Bulldog groups say the dogs can live healthy lives and many of the serious health problems can be attributed to irresponsible breeders.

Still, scientific studies show that given the level of inbreeding within some dog breeds, eliminating their health problems through breeding is challenging. Today's purebred bulldogs originated from a small group of founding animals, meaning there may not be enough genetic diversity within the current population to breed out problematic traits. Some veterinarians argue the exaggerated look of the dog's body exacerbates their health problems.

Studies show that short-nosed breeds experience more health issues than other dogs, including eye, spine, and skin problems. Because of their altered body shape, many cannot give birth naturally and have to deliver puppies by cesarean section.

The look of bulldogs, pugs and French bulldogs is controlled by the national club for each breed, which defines a "breed standard." For French bulldogs, it requires that thenose be "extremely short." In 2021, in response to criticism, the U.K.'s Kennel Club amended its French bulldog standard to specify that the dog's muzzle should be "well-defined."

Copyright 2024 NPR. To see more, visit www.npr.org.



Source link

IMARC Group’s report titled “Portable Oxygen Concentrators Market Report by Technology (Continuous Flow, Pulse Flow), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress Syndrome, Sleep Apnea, and Others), End User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032”. The global portable oxygen concentrators market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: www.imarcgroup.com/portable-oxygen-concentrators-market/requestsample

Factors Affecting the Growth of the Portable Oxygen Concentrators Industry:

  • Increasing Prevalence of Respiratory Diseases:

The rising number of individuals suffering from respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is supporting the growth of the market. These conditions often necessitate oxygen therapy to improve breathing and overall health. The global population is aging, and elderly individuals are more susceptible to respiratory diseases. The growing number of individuals who require oxygen therapy to manage their conditions is offering a favorable market outlook. Portable oxygen concentrators offer a convenient solution for these patients. Advancements in medical diagnostics and increased awareness of respiratory health are leading to earlier and more accurate diagnoses.

Individuals are becoming more susceptible to respiratory conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, and obstructive sleep apnea. These conditions often necessitate oxygen therapy. As the elderly population is growing, the number of individuals requiring oxygen support. Aging is often accompanied by the development of multiple chronic health conditions. Many elderly individuals have comorbidities that can exacerbate respiratory issues, making oxygen therapy crucial for their overall well-being. Elderly individuals prefer to receive medical care in the comfort of their homes whenever possible.

  • Advancements in Technology:

Technological innovations are making it possible to design smaller and lighter portable oxygen concentrators. This reduction in size and weight is significantly improving the portability of these devices, allowing patients greater freedom of movement. Modern portable oxygen concentrators feature advanced battery technology that provides longer operational hours on a single charge. This extended battery life enables patients to use the device for an extended period without needing frequent recharges.

Leading Companies Operating in the Global Portable Oxygen Concentrators Industry:

  • Caire Inc. (NGK Spark Plug Co. Ltd)
  • Chart Industries Inc.
  • Drive Devilbiss Healthcare Limited (Drive International LLC)
  • Inogen Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V
  • Nidek Medical India Pvt Ltd
  • O2 Concepts LLC
  • Precision Medical Inc. (BioHorizons Inc.)
  • Resmed Inc.
  • Teijin Limited

Portable Oxygen Concentrators Market Report Segmentation:

By Technology:

  • Continuous Flow
  • Pulse Flow

Pulse flow represents the largest segment as it offers a more efficient and tailored oxygen delivery method for patients with varying respiratory needs.

By Application:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Respiratory Distress Syndrome
  • Sleep Apnea
  • Others

Chronic obstructive pulmonary disease (COPD) accounts for the largest market share due to its reliance on long-term oxygen therapy.

By End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Ambulatory surgery centers hold the biggest market share as they frequently require portable oxygen concentrators to support patients during outpatient procedures and surgeries.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America enjoys the leading position in the portable oxygen concentrators market due to a large aging population and high prevalence of respiratory diseases.

Global Portable Oxygen Concentrators Market Trends:

The aging population is catalyzing the demand for portable oxygen concentrators. As the elderly population is growing, there is a higher prevalence of respiratory conditions, making these devices essential for managing health and improving the quality of life.

Ongoing technological innovations are leading to smaller, lighter, and more efficient portable oxygen concentrators. These advancements enhance device portability, battery life, and user-friendliness, making them more appealing to patients.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163



Source link

allergy
Credit: Pixabay/CC0 Public Domain

Spring allergies feel bad enough for people with nasal congestion and asthma symptoms. But imagine if aspirin is the culprit that makes everything feel worse and you didn't know it. For some people with aspirin-exacerbated respiratory disease (AERD), also known as Samter's triad, it can be a challenging and long road to diagnosis.

Dr. Angela Donaldson, a Mayo Clinic otolaryngologist, focuses her research on this condition that is difficult to diagnose.

Coughing, wheezing, sinus pressure, the list goes on. It might describe a diagnosis that, for some, has been historically missed—aspirin-exacerbated respiratory disease.

"These are patients who have horrible asthma. They also have nasal polyps, and they're allergic to aspirin," says Dr. Donaldson.

And aspirin doesn't cause new illness. It aggravates asthma and sinus issues for these patients.






Credit: Mayo Clinic

"It's a particular group of people who have been struggling with regular medical therapy that should work, and have both asthma that's difficult to control and sinus disease that's difficult to control," says Dr. Donaldson.

She says most patients suffer for years before the correct diagnosis and treatment. And that's a focus of her research.

"How best to get people to screen for that disease process, since it's kind of overlooked multiple times, and then get people back to their normal lives," she says.

Along with aspirin, people who are affected by AERD may have problems taking nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen. Aspirin or NSAIDs may be in cold medicines and other medications, so pay close attention to labels.

Treatments may include desensitization to aspirin and NSAIDs, surgery to remove nasal polyps, and therapeutics.

It's important to remember that a diagnosis is arduous because aspirin-exacerbated respiratory disease must include all three features of asthma, recurring nasal polyps, and problems with aspirin or NSAIDs.

Citation:
Video: Can aspirin make your breathing worse? (2024, March 27)
retrieved 27 March 2024
from medicalxpress.com/news/2024-03-video-aspirin-worse.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Source link

The global medical dynamometer market is experiencing rapid expansion, driven by the rising prevalence of musculoskeletal disorders and the growing emphasis on physical rehabilitation. Advanced technologies such as wireless connectivity and real-time data monitoring are enhancing the efficiency and accuracy of muscle strength assessment, fueling market growth. Additionally, increasing awareness about proactive healthcare management is driving demand for dynamometers in fitness centers, gyms, and home-based rehabilitation programs.

BOSTON, March 27, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Global Medical Dynamometer Market is estimated to increase from $547.5 million in 2023 to reach $780.1 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028."

This comprehensive report delves into the multifaceted landscape of the medical dynamometer market, spanning healthcare, rehabilitation, and research sectors. It provides an exhaustive analysis covering various types of dynamometers including hand, chest, squeeze, and push-pull variants. Targeting key stakeholders such as hospitals, rehabilitation centers, sports medicine facilities, and research labs, the report offers profound insights into market dynamics, current trends, and future potentials. By addressing drivers, challenges, and opportunities, it equips market players with strategic intelligence to navigate the evolving landscape. Moreover, the report elucidates industry status, recent developments, and emerging trends, enabling informed decision-making and fostering growth. Geographical nuances are meticulously examined, making it an invaluable resource for companies seeking to expand their market footprint. Whether for market incumbents, potential entrants, government agencies, or other interested parties, this report serves as a definitive guide to understanding and capitalizing on the dynamic medical dynamometer market.

The medical dynamometer has emerged as a pivotal tool in addressing clinical needs, particularly in precise ankle strength measurements. With its portability and high reliability, it proves to be indispensable for routine muscle strength monitoring across diverse populations, exhibiting robust agreement with the gold standard handheld dynamometer (HHD). Its versatility extends from children to the elderly and individuals with weak ankle strength, promising accurate measurements in clinical settings pending further validation. Adding to this landscape, Ashva WearTech's Fitmust introduces a handheld muscle strength dynamometer, poised to revolutionize muscle strength assessment. Launched in April, this microprocessor-based device offers precise and medically accurate measurements, aiding in injury assessment and rehabilitation. Fitmust addresses the critical aspect of muscle strength, recognized by physiotherapists and orthopedic surgeons as paramount in treatment protocols. By providing a comprehensive testing solution for various muscle groups, it empowers healthcare professionals with valuable insights for optimizing health and fitness outcomes.

Explore the full report on the burgeoning Global Medical Dynamometer Market for comprehensive insights and forecasts – click here to Learn More

Key Drivers of the Global Medical Dynamometer Market

Increase in Sports Injury: With the surge in the popularity of sports and physical activities, there has been a corresponding increase in sports-related injuries. Medical dynamometers are indispensable in this scenario, as they play a crucial role in assessing muscle strength and monitoring rehabilitation post-injury. These devices are in high demand due to their effectiveness in tracking progress during the recovery process, ensuring athletes and individuals can safely return to their activities.

Rise in Prevalence of Bone Injuries and Osteoporosis: The prevalence of bone injuries, fractures, and conditions such as osteoporosis is on the rise, particularly among the aging population. In addressing these challenges, medical dynamometers prove invaluable. They aid healthcare professionals in evaluating bone health and assessing muscle strength around affected areas. Early detection and continuous monitoring facilitated by these devices significantly contribute to better patient outcomes and improved quality of life.

Rehabilitation and Physiotherapy Trends: There has been a significant emphasis on rehabilitation and physiotherapy in recent years. In this evolving landscape, medical dynamometers serve as essential tools for therapists to design personalized exercise programs tailored to individual patient needs. By facilitating targeted muscle strength assessment and monitoring, these devices help patients regain strength, improve mobility, and enhance overall functional capacity, thereby accelerating the rehabilitation process.

Growing Geriatric Population and Increase in Orthopedic Surgeries: As the global population ages, there is a concurrent increase in age-related conditions and orthopedic surgeries. Joint replacements, fracture repairs, and other orthopedic procedures are becoming more prevalent. Medical dynamometers play a crucial role in this scenario, assisting healthcare providers in preoperative assessments, postoperative rehabilitation, and long-term monitoring of patients. By accurately assessing muscle strength and functional capacity, these devices contribute to optimized outcomes and improved post-surgery recovery trajectories.

Request a Sample Copy of the Global Medical Dynamometer Market Report.

Report Synopsis 

Report Metrics

Details

Base year considered

2022

Forecast Period considered

2023-2028

Base year market size

$516.0 million

Market Size Forecast

$780.1 million

Growth Rate

CAGR of 7.3% for the forecast period of 2023-2028

Segment Covered

Technology, Product Type, Application, End-User, and Geographic Region

Regions covered

North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Countries covered

U.S, Canada, France, Germany, Italy, Spain, UK, Russia, China, India, Japan, and Australia

Key Market Drivers

•  Increase in Sports Injury

•  Rise in Prevalence of Bone Injuries and Osteoporosis

•  Rehabilitation and Physiotherapy Trends

•  Growing Geriatric Population and Increase in Orthopedic Surgeries

Global Medical Dynamometer Market Segmentation Analysis

Technology Segmentation

Within the medical dynamometer market, technology segmentation categorizes devices into two main types: Electronic Dynamometers and Mechanical Dynamometers. Electronic Dynamometers employ electronic sensors to accurately measure muscle strength, offering real-time data for assessment. On the other hand, Mechanical Dynamometers rely on mechanical principles such as springs or levers for muscle strength assessment, providing a portable and cost-effective alternative.

Product Type Segmentation

The market for medical dynamometers further segments products into various types to cater to different assessment needs. Handheld Dynamometers are compact and easy-to-use devices suitable for assessing muscle strength in different body parts. Pinch-gauges are specialized tools designed to measure pinch strength, particularly useful in hand rehabilitation. Push-Pull Dynamometers evaluate upper and lower limb strength during pushing and pulling movements, while Squeeze Dynamometers measure grip strength, crucial for assessing hand function.

Application Segmentation

Medical dynamometers find application across various medical fields, including Orthopedics, Medical Trauma, Cardiology, and Neurology. In Orthopedic settings, these devices assist in preoperative assessments, postoperative rehabilitation, and monitoring orthopedic conditions. Medical Trauma applications involve evaluating muscle strength post-traumatic injuries. Cardiology utilizes dynamometers to assess cardiac muscle strength and endurance, while Neurology employs them in diagnosing and monitoring neurological conditions.

End-User Segmentation

End-user segmentation categorizes users of medical dynamometers into different groups. Hospitals commonly use dynamometers for patient assessment, rehabilitation, and monitoring. Physiotherapy Clinics utilize these devices for designing personalized exercise programs, while Rehabilitation Centers rely on them for patient recovery and functional improvement.

This report on the Global Medical Dynamometer Market provides comprehensive insights and analysis, addressing the following key questions:

1.  What is the projected market size and growth rate of the market?

The Global medical dynamometer market is projected to grow from $516.0 million in 2022 to $780.1 million in 2028, at a compound annual growth rate (CAGR) of 7.3 % during the forecast period.

2.  What are the key factors driving the growth of the market?

  •  Increase in sports injuries.
  •  Rise in prevalence of bones injuries and Osteoporosis
  •  Rehabilitation and Physiotherapy trends
  •  Growing Geriatric Population and increase in orthopaedic surgeries.

3.  What segments are covered in the market?

This report segments the market based on technology, type, application, end-user, and region. Based on the technology, the market is segmented into electronic dynamometer and mechanical dynamometer. Based on product type, the market is segmented into handheld dynamometer, pinch gauges, push-pull dynamometer, squeeze dynamometer and others. Based on application, the market is segmented into orthopedics, medical trauma, cardiology, neurology and others. Based on region, the market is segmented as North America, Europe, Asia-Pacific and Rest of the World.

4.  By Type, which segment will dominate the market by the end of 2028?

Handheld Dynamometer will dominate the market by the end of 2028.

5.  Which region has the highest market share in the market?

North America holds the highest share in the market.

Some of the Key Market Players Are:

  •  3B SCIENTIFIC GMBH
  • BIODEX MEDICAL SYSTEMS INC.
  • BIOMETRICS LTD.
  • BTE TECHNOLOGIES
  • CHARDER ELECTRONICS CO. LTD.
  • FABRICATION ENTERPRISES INC.
  • HERKULES KUNSTSTOFF OBERBURG AG
  • HOGGAN SCIENTIFIC LLC.
  • JLW INSTRUMENTS
  • JTECH MEDICAL INDUSTRIES INC.
  • KERN & SOHN GMBH
  • LAFAYETTE INSTRUMENT CO.
  • MARSDEN GROUP
  • NORTH COAST MEDICAL INC.
  • PERFORMANCE HEALTH
  • VERNIER SCIENCE EDUCATION
  • ZHONGSHAN CAMRY ELECTRONIC CO. LTD.

Browse Related Reports:

Global Market for Pain Management Drugs and Devices: This report refers to a comprehensive analysis of the global market for pain management drugs and devices, focusing on both current trends and future projections up to 2028. It delves into the market drivers, restraints, and challenges, while also providing insights into the competitive landscape and regulatory framework. Segmented by geography, product type (pharmaceuticals and medical devices), and application areas such as post-operative pain, neuropathic pain, and musculoskeletal pain, among others, the report offers a detailed examination of key market players and their strategies. Notably, the report excludes drugs or devices targeting specific conditions like rheumatoid arthritis but includes treatments aimed at alleviating associated pain symptoms. For instance, Enbrel is highlighted for its role in treating moderate-to-severe rheumatoid arthritis, while Celebrex is recognized for its efficacy in managing the signs and symptoms of osteoarthritis and rheumatoid arthritis, alongside the relief of acute pain.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with [email protected].  

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

Contact Us

Corporate HQ: BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, USA

Email: [email protected],

Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

SOURCE BCC Research LLC

Source link

A wearable heart rate monitor is an instance of a personal monitoring device. It allows for real-time heart rate monitoring. Wearable heart rate monitors come in wrist bands and chest straps. These are small and lightweight devices designed to work in harsh environments. Advanced features of heart rate monitors include activity, heart rate variation, breathing rate, and core temperature. The wrist band is a more popular heart rate monitoring device because it is comfortable and simple to use.

The Cardiac Monitoring Devices Market report is the most important research for who looks for complete information on the Cardiac Monitoring Devices market. The report covers all information on the global and regional markets including historic and future trends for market demand, size, trading, supply, competitors, and prices as well as global predominant vendor’s information. The forecast market information, SWOT analysis, Cardiac Monitoring Devices market scenario, and feasibility study are the vital aspects analyzed in this report.

The Cardiac Monitoring Devices Market is anticipated to grow from  USD 23.2 billion in 2024 to USD 34.01 billion by 2030, at a CAGR of 4.6% during the forecast period.

Top Leading Companies of Global Cardiac Monitoring Devices Market are:

Medtronic, Abbott, Boston Scientific Corporation, GE Healthcare, BIOTRONIK, and Koninklijke Philips N.V.

Get a free Sample Copy of this Report:

exactitudeconsultancy.com/reports…t-a-sample

The Cardiac Monitoring Devices Market segments and Market Data Break Down are illuminated below

Type Segment in Cardiac Monitoring Devices Market, 2019-2025, (in USD million)

ECG Devices

Resting ECG Devices

Stress ECG Devices

Holter Monitors

Implantable Loop Recorders

Mobile Cardiac Telemetry Devices

Cardiac Output Monitoring Devices

Event Monitors

Smart ECG Monitors

Type Segment in Cardiac Rhythm Management Devices Market, 2019-2025, (in USD million)

Defibrillators

Implantable Cardioverter Defibrillators

External Defibrillators

Pacemakers

Implantable Pacemakers

External Pacemakers

Cardiac Rhythm Management Devices Market End-User Segment, 2019-2025, (in USD million)

Hospitals & Clinics

Cardiac Centers

Ambulatory Surgery Centers

Other End Users

Wearable Heart Monitoring Devices Market Dynamics

Drivers

Rise in the number of geriatric and obese population

Because life expectancy has increased over time, more people are in their 60s and older. According to the United Nations Database on World Population Ageing 2020, there will be 1.5 billion elderly people worldwide by 2050, up from 727 million in 2020. Elderly people are more likely to sustain fall-related injuries, which can lead to a range of functional restrictions and a dependence on mobility aids. As a result, it is anticipated that the global geriatric population would grow dramatically, driving up the demand for patient handling and mobility equipment. The prevalence of obesity in the population is rising quickly.

In 2020, 39 million kids under the age of five will be overweight or obese.

Opportunities

Growing adoption rate of artificial intelligence and 5G

Furthermore, the increasing adoption of artificial intelligence and 5G will provide favourable opportunities for the wearable heart monitoring devices market growth. 5G can use artificial intelligence (AI) to determine a patient's potential diagnosis and treatments. Furthermore, AI can help healthcare systems predict which patients are likely to have postoperative complications, allowing for early intervention. Furthermore, the growing emphasis of manufacturers on the adoption of advanced technologies, as well as the increase in the number of emerging markets, will provide beneficial opportunities for the growth of the wearable heart monitoring devices market during the forecast period.

Regional Analysis for Cardiac Monitoring Devices Market:

  1. North American Market (USA, Canada, North America, Mexico),
  2. European Market (Germany, France, UK, Russia, Italy),
  3. Asia Pacific Market (China, Japan, South Korea, Asian Countries, India, Southeast Asia),
  4. South American Market (Brazil, Argentina ) , Colombia,.),
  5. Middle East and Africa Market (Saudi Peninsula, UAE, Egypt, Nigeria, South Africa)

Global Cardiac Monitoring Devices Market provides valuable insights such as: 

  • Nature of the competition in Global Cardiac Monitoring Devices Market
  • Key segments with largest share in Global Cardiac Monitoring Devices Market
  • Emerging technologies that can pave way for product innovation
  • Consumer purchasing trends related to the products and services in Global Cardiac Monitoring Devices Market
  • End-use industries expected to foster growth in the market
  • Impact of COVID-19 pandemic on manufacturing and production cycles in the Cardiac Monitoring Devices Market
  • Region-specific policy frameworks and regulatory guidelines
  • Unexplored geographical regions with lucrative opportunities for stakeholders in the market

Crucial Elements from the Table of Contents of Global Cardiac Monitoring Devices Market:

Chapter 1: Cardiac Monitoring Devices Market Overview
Chapter 2: Global Cardiac Monitoring Devices Market Competition, Profiles/Analysis, Strategies
Chapter 3: Global Cardiac Monitoring Devices Capacity, Production, Revenue (Value) by Region (2016-2021)
Chapter 4: Global Cardiac Monitoring Devices Supply (Production), Consumption, Export, Import by Region (2016-2021)
Chapter 5: Global Cardiac Monitoring Devices Market Regional Highlights
Chapter 6: Industrial Chain, Sourcing Strategy, and Downstream Buyers
Chapter 7: Marketing Strategy Analysis, Distributors/Traders
Chapter 8: Market Effect Factors Analysis
Chapter 9: Market Decisions for the present scenario
Chapter 10: Global Cardiac Monitoring Devices Market Forecast (2024-2030)
Chapter 11: Case Studies
Chapter 12: Research Findings and Conclusion

Explore Full Report With Detailed TOC Here:

exactitudeconsultancy.com/reports…es-market/

Key questions answered in the report:

  • What is the growth potential of the Cardiac Monitoring Devices market?
  • What growth opportunities might arise in the Cardiac Monitoring Devices industry in the years to come?
  • What are the most significant challenges that the Cardiac Monitoring Devices market could face in the future?
  • What are the key technologies and Cardiac Monitoring Devices Market trends shaping the Cardiac Monitoring Devices Market?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Cardiac Monitoring Devices Industry?

Report –

  • Analyzing the outlook of the market with the recent trends and SWOT analysis.
  • Market dynamics scenario, along with growth opportunities of the market in the years to come.
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects.
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and -strategies adopted by players in the past years.

Finally, the Cardiac Monitoring Devices Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. The Cardiac Monitoring Devices industry report additionally presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

Following are a few examples of the customization requests:

The Cardiac Monitoring Devices market is a diverse and constantly evolving industry, with a wide range of customization requests from clients. Here are a few examples of the most common customization requests:

  1. Personalization of products: Many clients in the Cardiac Monitoring Devices market request custom-made products that cater to their specific needs and preferences. This can include everything from customized packaging and branding to unique product features and sizes.
  2. Customized packaging: Packaging is a key component of any product, and clients in the Cardiac Monitoring Devices market often request customized packaging that reflects their brand identity and aesthetic. This can include custom labels, stickers, and even custom boxes with unique shapes and designs.
  3. Custom product formulations: Clients in the Cardiac Monitoring Devices market often request custom product formulations that are tailored to their specific needs.
  4. Exclusive collaborations: Many brands in the Cardiac Monitoring Devices market collaborate with influencers or celebrities to create limited-edition products or collections. These collaborations often feature exclusive packaging, unique product formulations, and special branding.

Additional paid Services: -

  • Client will get one free update on the purchase of Corporate User License.
  • Quarterly Industry Update for 1 Year at 40% of the report cost per update.
  • One dedicated research analyst allocated to the client.
  • Fast Query resolution within 48 hours.
  • Industry Newsletter at USD 100 per month per issue.

Get More:  exactitudeconsultancy.com/primary-research/

Thank you for your interest in the Cardiac Monitoring Devices Market research publications; you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asia.

News From

Exactitude Consultancy.Exactitude Consultancy.
Category: Industry Reports & Market Analysis Profile: Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
What we aim is to provide a holistic picture of the market taking into account all the possible market drivers.
With an aim to cover ...

This email address is being protected from spambots. You need JavaScript enabled to view it.

Source link

Approximately seven million Americans have scoliosis, a spine condition characterized by a curvature in the back. While it is most often diagnosed in children, adults can also develop scoliosis. Either way, you may wonder if it affects running.

Here, two scoliosis experts, Juan C. Rodriguez-Olaverri, M.D., Ph.D., a former runner with scoliosis and the director of pediatric deformity surgery and early onset scoliosis in the NYU Langone Department of Orthopedic Surgery, and Michelle Yang, DPT, C.S.C.S., a physical therapist at the Hospital for Special Surgery, answer questions about scoliosis and how it may affect runners.

What is scoliosis?

Everyone’s spine has normal curves from front to back, says Rodriguez-Olaverri. When you look at someone’s back from behind, most spines also appear straight from side to side. People with scoliosis, however, have spines that curve sideways when viewed from behind. Depending on where the spine curves, it may form an “S” or a “C” shape.

“There are many types of scoliosis,” Rodriguez-Olaverri tells Runner’s World. “You can have scoliosis in the thoracic [upper] spine or in the lumbar [lower] spine, [and] you can get scoliosis when you’re an adolescent or you can get scoliosis as an adult, and there’s scoliosis that needs surgery and scoliosis that doesn’t need surgery.”

In most scoliosis cases, the problem begins to develop for an unknown, or “idiopathic” reason, per the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Idiopathic scoliosis typically occurs in children aged 11 and older, and is more common in girls than boys. However, genetics may play a role in its development. Patients are more likely to have scoliosis if a parent or sibling has it.

More uncommonly, some babies are born with spinal abnormalities that develop before birth (congenital scoliosis). Others, as they get older, develop spinal changes that occur because of neurological or muscular diseases like cerebral palsy, muscular dystrophy (MS), and spinal cord injury, according to the American Association of Neurological Surgeons (AANS).

Sometimes, scoliosis can be so mild that it doesn’t cause symptoms or pain. In other cases, the curve can become so exaggerated that someone may have uneven shoulders (one or both shoulder blades may stick out), one hip appears higher than the other, or one side of the rib cage is higher than the other when bending forward. When scoliosis is severe, a person may have back pain and even difficulty breathing.

Can adults develop scoliosis?

Adults are at risk for developing degenerative scoliosis, which is also known as adult onset scoliosis. It is caused by degeneration of the spine as people age, and is considered completely different from juvenile or adolescent scoliosis. The difference is that an adult is considered “skeletally mature,” and is no longer growing.

Symptoms of degenerative scoliosis are similar to those found in other age-related back problems. You might feel back pain, pins and needles tingling in the leg, or numbness in the buttocks and legs. Finally, someone may feel sharp pain or one side of the spine may stick out a bit more than the other.

How is scoliosis diagnosed?

A doctor performs a physical examination to evaluate posture and check for asymmetries, and will likely order an X-ray to evaluate and measure the curve of the spine. If the curve is greater than 10 degrees, it is likely scoliosis. A curve is considered “significant,” say the experts, if it measures greater than 25 to 30 degrees and “severe” if it exceeds 45 to 50 degrees.

How is scoliosis treated?

Treatment for scoliosis varies depending on the age at diagnosis, the degree of curvature, and whether symptoms are present. The overall treatment goals are to stop or slow the spinal curve from worsening, prevent or decrease pain, improve posture, prevent or manage breathing problems, and boost quality of life.

You may not need treatment if the curve is mild, or if there is minimal concern that it will increase. However, people with scoliosis of any type and degree of curvature can benefit from physical activity. Yang encourages people to see a physical therapist for a top-down assessment to learn which exercises can help improve posture and prevent their scoliosis from progressing.

In addition, your doctor may recommend taking a spinal X-ray every five years—or sooner, if symptoms present—to ensure the curve isn’t worsening.

In general, surgery is only recommended if the spinal curve is greater than 50 degrees, the patient has nerve damage to their legs, and/or is experiencing curve-related bowel or bladder issues.

How does scoliosis affect running?

If you suffered with scoliosis as a teenager you should be able to run without limitations, unless you need future surgery, says Rodriguez-Olaverri. Those with degenerative scoliosis who have lower back pain should not run, he cautions, because that will place additional pressure on the lumbar spine and worsen the pain.

If your spinal curve affects your lungs, running may be less comfortable. Sometimes, the curves can decrease space in the ribcage, which can limit how much air you’re able to inhale with one breath, which is known as vital capacity, Yang says. So, you may find that you get out of breath easily. One major benefit of running, though, is that it forces you to breathe harder, repeatedly, which makes your lungs stronger over time, Yang notes.

Scoliosis may also create issues with running if there are significant asymmetries between the two sides of the body. “Some people with scoliosis actually have leg-length discrepancies, so one leg might be a bit shorter than the other,” Yang says. This asymmetry can put more load on one leg while you run, increasing your risk for injuries like bone stress fractures.

Also, asymmetries between your shoulder heights can affect running posture. Having one shoulder that’s higher than the other can cause you to slouch forward or lean more heavily to one side, Yang says. As you get fatigued, this forward slouch or side-lean can become more exaggerated.

One of the primary goals for people with scoliosis is improving their posture to prevent the spinal curve from worsening. Running with poor posture won’t help you achieve this goal. Yang recommends seeing a physical therapist or orthopedist if you experience pain, discomfort, or have questions about running safely. People with scoliosis benefit from a running form assessment, and the healthcare professional can offer specific exercises and advice to improve posture and form.

Can running improve scoliosis?

Despite the potential risks, running can be helpful for people with scoliosis. “I’m a huge advocate for people with scoliosis participating in any type of physical activity, which includes running,” Yang says. “It allows for symmetrical movement and helps engage your postural muscles overall, as well as keeping your core strong, which is really important” Strong core muscles help support your trunk, taking some of the burden off your spine.

Watching your running form is essential to reaping these benefits. If you can, get a running gait analysis. This way, a running professional can recommend how to improve your form and technique.

Here is a general running form checklist from the experts:

  • Move your arms from the shoulders, not the elbows.
  • Bring your heels toward your buttocks.
  • Gaze directly in front of you; don’t tilt your chin up or down.
  • Pull your shoulder blades back (pretend you’re squeezing a pencil between your shoulder blades).
  • Lean forward slightly from your ankles.

It’s always best to chat with your doctor first, though, before starting a running routine. That’s especially true for those with degenerative scoliosis, because as lumbar disks (spongy pads between the bones that make up the lower portion of the spine) wear down, you may need to do low- or no-impact exercise. “If you have scoliosis in the lumbar spine and your disks are degenerating, you don’t want to keep banging on those disks because they’re going to get worse,” Rodriguez-Olaverri says.

Having your doctor on board is especially important if you have higher-degree curvature. “With the higher-degree curvature, you worry about posture getting worse over time, so that’s a conversation to have with a doctor to make sure they’re doing the proper things to help decrease the curvature in their spine,” Rodriguez-Olaverri says.

Lettermark

Lauren Bedosky is a freelance health and fitness writer who specializes in covering running and strength training topics. She writes for a variety of national publications, including Runner’s WorldPrevention, Experience Life and Women’s Running.

Source link

Future Market Insights Global and Consulting Pvt. Ltd.

Future Market Insights Global and Consulting Pvt. Ltd.

US respiratory biologics market to surge at 13.7% CAGR. Growing awareness & innovation by US biotech companies fuel market. The growth of the respiratory biologics market is fueled by a rising incidence of respiratory diseases such as asthma, COPD, allergic rhinitis, and other pulmonary disorders, reflecting a global trend towards higher prevalence rates.

NEWARK, Del, March 26, 2024 (GLOBE NEWSWIRE) -- As per Future Market Insights (FMI), global respiratory biologics market are estimated to be worth US$ 8,154.6 million in 2024. The market is expected to reach US$ 42,319.9 million, expanding at a CAGR of 17.9% through 2034. The global prevalence of respiratory diseases is surging, fueled by factors such as air pollution, smoking, and aging populations are driving the demand for respiratory biologics.

As the global population ages, respiratory diseases are anticipated to escalate, placing heightened strain on healthcare systems. In response to these challenges, there is a burgeoning demand for respiratory biologics offering targeted medication delivery to the lungs.

Request A Sample Copy of This Report: www.futuremarketinsights.com/reports/sample/rep-gb-19249

Respiratory biologics have significantly transformed the respiratory treatment landscape by offering targeted approaches to modulate specific pathways involved in the pathogenesis of respiratory diseases. This precision targeting not only improves symptom control but also reduces exacerbations, enhances lung function, and enhances patients' quality of life.

In navigating the evolving landscape of respiratory health, respiratory biologics stand out as a promising avenue for advancing therapeutic strategies and improving the quality of care for individuals grappling with respiratory conditions.

Key Takeaways from the Market Study:

  • Asthma is set to hold a lucrative market share of 82.3% by disease indication in 2024. 

  • By route of administration, the intravenous segment held a 67.0% market value share in 2023.

  • France is projected to rise at 16.3% CAGR during the forecast period

  • The United States is expected to exhibit a CAGR of 13.7% throughout the forecast period.

  • By 2034, China is expected to grow with a CAGR of 18.9%. 

"The respiratory biologics market is advancing in research and development to expand treatment options and address medical needs. However, challenges such as high costs, access barriers, potential side effects, and complexities in the regulatory landscape pose significant challenges for manufacturers in the market," opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Click for Methodology Details: www.futuremarketinsights.com/request-report-methodology/rep-gb-19249

Competitive Landscape:

The respiratory biologics market encourages collaborative innovation, with pharmaceutical companies and outsourcing collaborating to advance technologies, overcome challenges, and bring novel therapies to market.

For instance,

  • In July 2020, Teva Pharmaceuticals announced a new strategic emphasis in Japan. The company redirected its business venture in Japan, prioritizing specialty assets and a curated generics portfolio tailored to patients' specific medical requirements.

  • In October 2021, Amgen acquired Teneobio, Inc. to advance its research and development activities to develop highly innovative patient products.

Key Companies Profiled:

  • GSK plc.

  • AstraZeneca

  • Sanofi and Regeneron Pharmaceuticals, Inc.

  • Genentech USA, Inc.

  • Teva Respiratory, LLC.

  • Novartis Pharmaceuticals Corporation

  • GlaxoSmithKline

  • Novartis

  • Roche

  • Boehringer Ingelheim

  • Regeneron Pharmaceuticals

  • Merck & Co.

  • Johnson & Johnson

  • Amgen

  • Biogen

  • Vertex Pharmaceuticals

  • Genentech (a member of the Roche Group)

  • AbbVie

Direct Purchase this Report now: www.futuremarketinsights.com/checkout/19249

Respiratory Biologics Market Segmentation by Category:

By Disease Indication:

By Route of Administration:

By Sales Channel:

  • Hospitals

  • Specialty Clinics

  • Retail Pharmacies

  • Mail Order Pharmacies

By Region:

  • North America

  • Latin America

  • East Asia

  • South Asia & Pacific

  • Western Europe

  • Eastern Europe

  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

  • Orthobiologics Market Size: The orthobiologics market is anticipated to expand its boundaries at a CAGR of 3.0% during the forecast period. The market holds a share of US$ 6.0 billion in 2023, while it is expected to cross a value of US$ 8.1 billion by 2033.

  • Respiratory Pathogen Testing Kits Market Share: As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4,083.1 million. By 2033, the valuation is expected to be worth US$ 7,136.8 million.

  • Molecular Respiratory Panels Market Growth: The molecular respiratory panels market size is projected to be worth US$ 1.1 billion in 2023. The market is likely to surpass US$ 2.0 billion by 2033 at a CAGR of 6.3% during the forecast period.

  • Respiratory Distress Syndrome Management Market Demand: The global respiratory distress syndrome management market is slated to reach a valuation of US$ 115.4 billion in 2023. According to Future Market Insights, the market is expected to grow at a 4.41% CAGR until 2033, valued at US$ 177.7 billion.

  • Respiratory Inhaler Devices Market Trends: The global respiratory inhaler devices market size is anticipated to attain an impressive valuation of US$ 37,258.5 million in 2023 and is projected to reach US$ 60,114.7 million by 2033, trailing a CAGR of 4.90% during the forecast period.

  • Respiratory Devices Market Opportunity: The respiratory devices market size is projected to be valued at US$ 24.2 Billion in 2023 and is expected to rise to US$ 55.9 Billion by 2033. The sales of respiratory devices are expected to grow at a significant CAGR of 8.7% during the forecast period.

  • Respiratory Measurement Devices Market Overview: The global respiratory measurement devices market was valued at around US$ 7.9 Billion at the end of 2021. The market is projected to register a 5.1% CAGR and top a valuation of US$ 13.5 Billion by 2032.

  • Human Respiratory Syncytial Virus (RSV) Treatment Market Outlook: In 2022, the human respiratory syncytial virus (RSV) treatment market is anticipated to be worth US$ 1,533.74 million in terms of revenue. The market is projected to expand at a CAGR of 11% to reach a market size of US$ 4,354.93 million by 2032.

  • Respiratory Analysers Market Development: The global respiratory analysers market is anticipated to be worth US$ 2.99 Billion in terms of revenue in 2022. The market is projected to expand at a CAGR of 15.87% to reach a market size of US$ 13.04 Billion by 2032.

  • Pediatric Respiratory Syncytial Virus Infection Market Forecast: The global pediatric respiratory syncytial virus infection market is valued at US$ 2,041 million as of 2022. The market is expected to grow at a CAGR of 15.2% during the period 2022-2032, and is projected to be valued at US$ 8,401.71 million by 2032.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Source link

In the journey towards a world free of Tuberculosis (TB), the crucial first step begins with identifying individuals affected by the disease.

Globally, around 1.3 million people died from TB in 2022, making it the second leading infectious killer after COVID-19, according to the World Health Organization (WHO).

However, many people with the disease, which is particularly prevalent in the Asia Pacific region and Africa, do not even get properly diagnosed.

Public health experts say the task of tracing these missing cases requires a three-pronged approach, involving community engagement, scaling-up the use of available technologies, and effective program management.

"By putting communities at the core, you ensure that they are fully involved in the process of making their villages TB-free," said Prabodh Bhambal, executive director of the Union South East Asia (USEA) Trust, at a webinar organized by Citizen News Service (CNS) this week (19 March).

The USEA Trust is an independent trust hosted by the International Union Against Tuberculosis and Lung Disease (The Union) in New Delhi, with a flagship project that aims to transform 1,000 villages into TB-free villages with support from the JSW Foundation, the social development arm of JSW Group, an Indian conglomerate whose businesses include steel, cement, automotive and paints.

The WHO estimates that India grapples with the world’s most extensive tuberculosis epidemic. In 2022, the country reported an incidence rate of 199 cases per 100,000 individuals in its population.

In Uganda, where there was a similar incidence rate of 198 cases per 100,000, the government is using mobile vans to conduct screenings in local communities as part of an awareness, testing and prevention campaign.

At the core of the campaign is the acknowledgment that relying solely on communities to visit health facilities doesn’t ensure uptake of services or effectively control TB at the community or household level.

The campaign emphasises the need for a collective desire for change, inspiring individuals to take action and voluntarily seek healthcare services. The aim is to enhance case-finding, address missing TB cases within communities, tackle treatment defaulting, and improve the use of prevention measures.

Stavia Turyahabwe, assistant commissioner for TB and Leprosy at Uganda’s Ministry of Health, says this approach has been highly effective. In 2022, more than 94,000 Ugandans were diagnosed with TB through the initiative, significantly contributing to improved disease detection rates, she told a two-day summit on TB and leprosy in Kampala this week (19-20 March).

However, she added that the ministry had yet to assess its impact on TB prevalence.

Harnessing technology, AI

Bhambal suggests that, by effectively harnessing current technologies for TB screening and diagnosis, a substantial portion of the undetected TB cases can be identified.

“In the small population of 5,000 people that we have screened so far under our project, we screened based on symptoms, used portable X-rays, and utilised an AI app.”

“Through this comprehensive approach, we have successfully detected cases of TB that would have otherwise been missed if we had relied solely on symptoms,” explained Bhambal, adding: “Technology plays a crucial role in finding these cases; we just need to find the right mix.”

Charles Olaro, director of clinical services at Uganda’s Ministry of Health, highlighted various innovations being employed in the country’s fight against TB, including GeneXpert technology, which rapidly diagnoses TB disease and drug resistance.

“We are not solely dependent on the microscope,” he said. “For any slides that test positive, we analyze them for drug resistance using the GeneXpert.”

Sriram Natarajan, co-founder of Indian diagnostics company Molbio Diagnostics, highlighted the limitations of microscopy in terms of detection.

However, he added that over the last decade, the WHO has approved molecular diagnostic tools capable of being deployed even in the doctor’s surgery.

He said these molecular tools boast sensitivity rates of up to 98 per cent, meaning that patients can be diagnosed at an early stage. However, despite these tools being available for about a decade, only about 25 to 30 per cent of TB cases globally are being diagnosed using them, according to Natarajan.

“We now have at least two available tools, but the uptake remains a major concern,” he told the CNS webinar.

“Both countries and their programs need to commit to implementing these tools at the primary level to ensure that everyone receives a molecular test as a confirmatory tool.”

Investment ‘crucial’

Natarajan says more commitment is needed from global funding agencies to focus on making these tools affordable and accessible to all.

“If we truly want to end TB by the target year of 2030, these interventions need to be scaled up and accelerated,” he added. “It’s crucial that these efforts are taken seriously.”

Lucica Ditiu, executive director of the Stop TB Partnership, told the CNS webinar: “It is possible to end TB. We see high-burden countries finding and treating TB.”

High-burden countries include India, Indonesia, Bangladesh, Nigeria, South Africa and Ethiopia.

“I want to say that, in many countries, private sector engagement is crucial to finding and treating all TB patients,” Ditiu added.

Guy Marks, respiratory medicine expert at the University of New South Wales and president and interim executive director of The Union, says TB must be treated as a public health problem, not merely an individual patient care issue.

“We must be brave and recognize that the current strategy to end TB in high-burden countries is not achieving the results we hope for,” he said.

“We need to change our approach if we are to win the fight against this infectious disease.”

Source link

Doctors cure sometimes, treat often, but comfort always — and guided by that saying, Dr Lim Zhen Wei made the decision early in his career to practise anaesthesiology — and later to specialise in pain medicine.

Dr Lim performs a staged procedure to dull pain in the spine. The nurses and radiographer wear protective vests as a fluoroscope, essentially an x-ray, is used to help pinpoint the exact area of pain.

THE discipline fascinated him as he viewed anesthesiologists as being able to exercise exact control over the human body, and to practise medicine with what he describes as instant benefits for his patients.

“Anaesthesiologists play a very important role in making patients comfortable and lessening anxiety during and after surgery by precisely managing human physiology like blood pressure, breathing volume, and body temperature,” said Dr Lim, who is Consultant, Department of Pain Medicine, Pain Management Centre (PMC), Singapore General Hospital (SGH).

“Pain medicine is a natural extension of practising anaesthesiology where I lessen patients’ pain, frequently after surgeries or secondary to another disease.”

Dr Lim feels a great sense of achievement when he can help his patients overcome their pain.

“I once treated a 60-year-old who was limping into the procedure suite in the morning but was hopping out of PMC by lunchtime,” he said.

His patients are a diverse group, ranging from teenagers to nonagenarians, with complaints such as painful joints in their limbs and even the spine.

Their pain might have resulted from sports activities, accidents, or just age-related wear-and-tear.

Most, however, seek help to manage their pain because they are not keen on more invasive treatments like surgery.

Dr Lim recalled a female patient in her late 60s with osteoarthritis in both knees.

“She was petrified at the idea of undergoing surgery. I did a right knee genicular nerve ablation treatment and her knee pain was reduced substantially,” he said.

Dr Lim used the same treatment on a younger man in his early 40s who also had knee pain.

In his case, jogging, golf and other activities had worn out his knees, causing pain.

The man did not want surgery as he felt his symptoms were relatively mild.

After positioning a needle next to the nerve causing pain and numbing it with state-ofthe- art cooled radio frequency ablation, the patient was able to return to what he was doing before.

“Numbing the nerve — a pure sensory nerve that does not supply any motor function — reduces the pain,” said Dr Lim.

Dr Lim has a keen interest in horology, the art of making clocks and watches.

For many patients, having the pain reduced to a level that enables them to get on with life is sufficient.

Making the patient more comfortable, even without correcting the underlying disease, is vital.

The natural reaction of someone with a painful left knee is to use their right knee more to avoid putting pressure on the painful knee.

But over time, the patient could start feeling pain in the right knee.

“It is important that we treat the pain early so that the patients can continue to maintain a balanced posture. It slows down the progression of the disease. For many patients, that is enough,” said Dr Lim.

Dr Lim sees the practice of medicine as both an art and science.

So perhaps it is not surprising that he should have an interest in horology, the art of making clocks and watches.

“Other than good clinical acumen and skills, a good doctor must also be able to build rapport and make patients feel at ease.

With advances in AI (artificial intelligence) and technology replacing many things in our lives, a good horological creation will remain relevant, just like a good doctor-patient therapeutic relationship, which cannot be replaced by AI,” he said.

Dr Lim, who shares young children — a girl and boy, aged five and two respectively — with his teacher wife, also enjoys travelling as a family.

“Travelling helps us understand the world around us and gain perspective on our own lives by seeing what others are going through. It truly is another form of education. Most importantly, it makes memories that last a lifetime.”








Source link

Today's early morning highlights from the major news organizations.


KFF Health News:
A Mom’s $97,000 Question: How Was Her Baby’s Air-Ambulance Ride Not Medically Necessary?


Sara England was putting together Ghostbusters costumes for Halloween when she noticed her baby wasn’t doing well. Her 3-month-old son, Amari Vaca, had undergone open-heart surgery two months before, so she called his cardiologist, who recommended getting him checked out. England assigned Amari’s grandparents to trick-or-treat duty with his three older siblings and headed to the local emergency room. (Castle Work, 3/25)


KFF Health News:
After Appalachian Hospitals Merged Into A Monopoly, Their ERs Slowed To A Crawl


In the small Appalachian city of Bristol, Virginia, City Council member Neal Osborne left a meeting on the morning of Jan. 3 and rushed himself to the hospital. Osborne, 36, has Type 1 diabetes. His insulin pump had malfunctioned, and without a steady supply of this essential hormone, Osborne’s blood sugar skyrocketed and his body was shutting down. ... After 12 hours in the waiting room, Osborne said, he was moved to an ER bed, where he stayed until he was sent to the intensive care unit the next day. (Kelman and Liss, 3/25)


KFF Health News:
A Paramedic Was Skeptical About This Rx For Stopping Repeat Opioid Overdoses. Then He Saw It Help


Fire Capt. Jesse Blaire steered his SUV through the mobile home park until he spotted the little beige house with white trim and radioed to let dispatchers know he’d arrived. There, Shawnice Slaughter waited on the steps, wiping sleep from her eyes. ... Three days earlier, Blaire — a paramedic who leads the fire department’s emergency medical team — met Slaughter at a nearby hospital. She had overdosed on opioids. It took four vials of an overdose reversal medication and dozens of chest compressions to get her breathing again. (Peace, 3/25)


The Washington Post:
Kate Middleton’s Diagnosis Comes Amid Rise In Some Early-Onset Cancers


The cancer diagnosis for Catherine, Princess of Wales, comes amid rising rates of certain cancers among young people globally. Although details of her condition remain sparse, doctors said the illness of the 42-year-old royal underscores the importance of cancer screening for people who have higher risk factors such as a family history of the disease. ... Catherine’s global celebrity and acknowledgment of her cancer, experts said, could shine a light on a troubling rise in certain cancers among people under 50. (Ovalle and Achenbach, 3/22)


The New York Times:
Diagnosis Of Princess Kate’s Cancer Followed Familiar Pattern, Doctors Say


Although it is not known what type of cancer Princess Catherine has, oncologists say that what she described in her public statement that was released on Friday — discovering a cancer during another procedure, in this case a “major abdominal surgery” — is all too common. “Unfortunately, so much of the cancer we diagnose is unexpected,” said Dr. Elena Ratner, a gynecologic oncologist at Yale Cancer Center who has diagnosed many patients with ovarian cancer, uterine cancer and cancers of the lining of the uterus. (Kolata, 3/22)


Fortune:
Katie Couric Says Too Many People Think Colorectal Cancer Is A Man’s Disease. She's Imploring Women To Get Potential Lifesaving Screenings


The risk of developing colorectal cancer is 1 in 23 for men and 1 in 25 for women, according to the American Cancer Society.  “Women, especially younger women, believe this is an old man’s disease, and that’s simply not true,” she says. “Women are diagnosed with colorectal cancer as often as men. I think sometimes people get colons and prostates confused.” ... Colorectal cancer is the second leading cause of cancer death in the U.S., and over 50,000 people are estimated to die from the diagnosis in 2024. (Mikhail, 3/22)


Fortune:
Does Medicare Cover A Colonoscopy? Yes, And Several Other Colorectal Cancer Screening Tests, Too


Colorectal cancer is the third most common cancer worldwide. Older adults should take note: “Most cases of colorectal cancer are detected after age 55, and the risk increases with age,” says Dr. Josh Forman, a gastroenterologist at the University of Maryland St. Joseph Medical Center and GastroHealth Towson. The good news: Early detection can prevent over 90% of colorectal cancer-related deaths. But almost 30% of people between ages 50 and 75 have not gotten screened. (Zable Fisher, 3/22)


Reuters:
US FDA Grants Full Approval To AbbVie's Ovarian Cancer Therapy


he U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie's (ABBV.N) "guided missile" cancer therapy, Elahere, for patients with a type of ovarian cancer. Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or walls of the abdomen, and have received one to three prior lines of treatment, according to the FDA. (3/22)


AP:
Mifepristone Access Is Coming Before The US Supreme Court. How Safe Is This Abortion Pill? 


The U.S. Supreme Court will take up a case Tuesday that could impact how women get access to mifepristone, one of the two pills used in the most common type of abortion in the nation. The central dispute in the case is whether the Food and Drug Administration overlooked serious safety problems when it made mifepristone easier to obtain, including through mail-order pharmacies. (Ungar and Perrone, 3/24)


Modern Healthcare:
How FDA Approval Could Jumpstart AI Use In Medical Devices


When it comes to commercializing artificial intelligence solutions, many digital health companies face a long road that runs directly through Silver Spring, Maryland. Silver Spring is the headquarters of the Food and Drug Administration, the agency providing clearances, designations and approvals for an increasing number of AI-enabled medical device and software products. (Perna, 3/22)


CNBC:
Nvidia's AI Ambitions In Medicine And Health Care Are Becoming Clear


Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health care developments at its 2024 GTC AI conference, — which also included the launch of roughly two dozen new AI-powered, healthcare-focused tools — demonstrate just how important medicine is to Nvidia’s non-tech sector revenue opportunities in the future. (Castillo, 3/24)


Politico:
Who Pays When AI Steers Your Doctor Wrong?


Doctors using new artificial intelligence tools to help them diagnose and treat their patients say they wish Congress would provide some clarity on a big unanswered question: Who pays if AI makes a mistake? Advancements in AI promise to improve care, but only if doctors trust the systems and are protected from liability, according to the country’s leading physicians’ group, the American Medical Association. (Payne, 3/24)


Modern Healthcare:
Congress Passes $1.2T Spending Bill That Includes HHS Funding


Congress passed the final measure early Saturday morning funding Health and Human Services Department operations, among other government programs, for the remainder of the fiscal year. Congress struggled for months to move the 12 annual appropriations bills it is supposed to pass by Sept. 30 every year. Having missed the regular deadline, it repeatedly passed stopgap funding bills to keep the government open. (McAuliff, 3/23)


The Hill:
Global AIDS Program Survives, But Backers ‘Not Satisfied’


America’s global AIDS relief program has been authorized for another year in the bipartisan budget deal, but public health advocates say the single year sends a worrying signal about U.S. commitment on the issue moving forward. ... It’s the first time the program has not been given a five-year extension. (Choi, 3/23)


Reuters:
US Appeals Court Curtails EPA's Ability To Regulate PFAS Under Toxic Substances Law


A federal appeals court has vacated two U.S. Environmental Protection Agency orders prohibiting a Texas plastics treatment company from manufacturing toxic “forever chemicals” while treating plastic containers used to hold things like pesticides and household cleaners. A unanimous three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals on Thursday agreed with Inhance Technologies that the EPA overstepped its authority by issuing the orders, since they were rooted in a section of the federal toxic chemical law reserved for regulating "new" chemicals. (Mindock, 3/22)


Newsweek:
FDA Settles Lawsuit Over Ivermectin Social Media Posts


The FDA has agreed to delete and never republish several social-media posts suggesting that ivermectin, a drug that some doctors used to treat COVID-19, is for animals and not humans. While the FDA still does not approve of using ivermectin to treat COVID, it settled Thursday a lawsuit brought by three doctors who sued it, as well as the Department of Health and Human Services and its secretary, Xavier Becerra, and FDA secretary Robert Califf. All parties have settled. (Bond, 3/22)


The New York Times:
Kamala Harris Visits Parkland And Urges States To Adopt Red-Flag Gun Laws


Vice President Kamala Harris on Saturday toured the still-bloody and bullet-pocked classroom building in Parkland, Fla., where a gunman killed 14 students and three staff members in 2018, using the grim backdrop to announce a new federal resource center and to call for stricter enforcement of gun laws. The freshman building at Marjory Stoneman Douglas High School had been preserved as evidence for criminal trials and is set to be demolished this summer. (Shear, 3/23)


The Hill:
Biden Campaign Uses ObamaCare Anniversary To Hammer Trump On Health Care


President Biden is using the anniversary of the Affordable Care Act’s (ACA) passage to hammer former President Trump’s record on health care and capitalize on his threats to repeal the law. In a new digital ad released Friday ahead of the 14th anniversary of the law, the Biden campaign sought to highlight Trump’s repeated repeal threats and underscore the consequences if he were to win a second term. (Weixel, 3/22)


The New York Times:
How A Pandemic Malaise Is Shaping American Politics


In March 2020, when Joseph R. Biden Jr. and Donald J. Trump competed for the White House for the first time, American life became almost unrecognizable. A deadly virus and a public health lockdown remade daily routines with startling speed, leaving little time for the country to prepare. ... Public confidence in institutions — the presidency, public schools, the criminal justice system, the news media, Congress — slumped in surveys in the aftermath of the pandemic and has yet to recover. (Lerer, Medina, and Epstein, 3/24)


The New York Times:
U.S. Measles Cases Surpass 2023 Levels, C.D.C. Says


There have now been 64 measles cases in the United States this year, surpassing the total of 58 cases in all of 2023, according to new data from the Centers for Disease Control and Prevention. The rise in cases should “alert us, rather than alarm us,” said Dr. Demetre Daskalakis, director of the National Center for Immunization and Respiratory Diseases at the C.D.C. (Blum, 3/22)


Reuters:
Measles Cases In US Rise To 62 As Of Thursday, Says CDC


The U.S. Centers for Disease Control and Prevention (CDC) said on Friday the number of measles cases in the United States has increased to 62 as of Thursday, higher than the whole of last year. The CDC issued a health advisory on Monday urging people, particularly children and international travelers, to get vaccinated against measles due to the increase in cases this year. Total cases were at 58 last week. (3/22)


CIDRAP:
US Flu Activity Declines, Along With Other Respiratory Viruses 


Flu activity finally declined last week following a lengthy post-holiday bump, though levels are still elevated, the Centers for Disease Control and Prevention (CDC) said today in its latest weekly FluView report. In its weekly respiratory virus snapshot, the CDC said indicators of COVID and respiratory syncytial virus (RSV) also declined. (Schnirring, 3/22)


NPR:
Starbucks Mug Recall: More Than 440,000 Mugs Recalled After Injury Reports


Nestlé says it is recalling more than 440,000 Starbucks mugs that were recently sold, following reports of at least a dozen people suffering severe burns or cuts on their hands or fingers after using the product. The mugs were manufactured by Nestlé USA and sold as part of a 2023 holiday Starbucks-branded gift set sold online and at Target, Walmart and Nexcom, a military retail outlet, according to a recall notice posted on Thursday by the U.S. Consumer Product Safety Commission. (Franklin, 3/21)


The New York Times:
Patients Hate ‘Forever’ Drugs. Are Ozempic And Wegovy Different? 


Most people, study after study shows, don’t take the medicines prescribed for them. It doesn’t matter what they are — statins, high blood pressure drugs, drugs to lower blood sugar, asthma drugs. Either patients never start taking them, or they stop. ... But that resistance may be overcome by the blockbuster obesity drugs Wegovy and Zepbound, which have astounded the world with the way they help people lose weight and keep it off. (Kolata, 3/24)


CIDRAP:
Study Highlights Potential To Reduce Antibiotic Use In Newborns


A large nationwide study in Sweden found that low exposure to antibiotics in newborns treated in neonatal units over a 9-year period was not associated with an increased risk of early-onset sepsis (EOS), researchers reported today in JAMA Network Open. But the study also found that the number of newborns who are treated with antibiotics is higher than it should be, given the low prevalence of EOS and low mortality associated with the condition, a finding the study authors say indicates that efforts to reduce unnecessary antibiotic use in newborns are needed. (Dall, 3/22)


CIDRAP:
New Data Show Paxlovid Outperforms Molnupiravir Against Severe COVID-19 Outcomes


A large study yesterday in the International Journal of Infectious Diseases shows that, if prescribed within 5 days of confirmed infection, Paxlovid (nirmatrelvir-ritonavir) is more effective in protecting against all-cause mortality and severe COVID-19 in adults than is molnupiravir, another antiviral drug. The study was conducted in Hong Kong in 2022. (Soucheray, 3/22)


CIDRAP:
Study Finds Bivalent COVID Vaccine Not Tied To Stroke Risk


Earlier this week in JAMA, researchers published data on the risk of stroke among Medicare beneficiaries aged 65 years and older in the immediate weeks following a bivalent (two-strain) COVID-19 vaccine dose, finding no significantly elevated risk during the first 6 weeks following injection. (Soucheray, 3/22)


CIDRAP:
New Neurologic Issues Less Likely After Severe COVID Than Flu, Research Suggests


Adults hospitalized for COVID-19 were at lower risk of needing medical care for migraine, epilepsy, neuropathy, movement disorders, stroke, and dementia in the next year than matched patients with influenza, researchers from Yale University and the University of Michigan report in Neurology. They point out, however, that their study did not assess the effects of long COVID. (Van Beusekom, 3/22)


The New York Times:
What’s Next For The Coronavirus?


Rat droppings from New York City. Poop from dog parks in Wisconsin. Human waste from a Missouri hospital. These are some of the materials that are readying us for the next chapter of the coronavirus saga. More than four years into the pandemic, the virus has loosened its hold on most people’s bodies and minds. But a new variant better able to dodge our immune defenses may yet appear, derailing a hard-won return to normalcy. Scientists around the country are watching for the first signs. (Mandavilli, 3/22)


CNN:
Eli Lilly Warns Of Temporary Short Supply Of Two Insulin Products 


Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The 10-milliliter vials of Humalog and insulin lispro injection will be in short supply at wholesalers and some pharmacies, Lilly said in a statement posted online Wednesday. (Tirrell, 3/22)


Reuters:
UnitedHealth Unit Will Start Processing $14 Billion Medical Claims Backlog After Hack


UnitedHealth Group (UNH.N) said on Friday its Change Healthcare unit will start to process the medical claims backlog of more than $14 billion as it resumes some software services disrupted by a cyberattack last month. The company has been scrambling to resume services at the technology unit that was hit by a cyberattack on Feb. 21, disrupting payments to U.S. doctors and healthcare facilities and forcing the U.S. government to launch a probe. (Leo, 3/22)


Modern Healthcare:
Claim Denials Cost Hospitals $20 Billion In 2022: Premier Report 


Hospitals and health systems spend an estimated $19.7 billion a year managing denied claims for care, a new report shows. Premier, a group purchasing and consulting organization that works with thousands of providers, polled 516 hospitals that offered their 2022 claims data. Nearly 15% of claims, on average, were denied at a cost of close to $44 a claim, excluding related clinical labor expenses, the survey found. (Kacik, 3/22)


Modern Healthcare:
Tenet-Leased Facilities Sold To Sila Realty Trust


Five healthcare properties leased by Tenet Healthcare in Arizona and Texas were acquired by Sila Realty Trust Inc. in a $85.5 million deal. The seller was not disclosed. The five facilities operate under local, Tenet-affiliated hospital brands. Tenet does not own any of the acquired properties, a spokesperson for Sila Realty said. (DeSilva, 3/22)


Reuters:
Nursing Home Co. Petersen Health Likely To Break Up In Bankruptcy Sale


Elder care company Petersen Health Care plans to sell its nursing homes to new care providers in bankruptcy, likely dividing its assets among multiple buyers, a company attorney said Friday. Petersen believes that its nursing homes may be worth between $215 million and $305 million, as long as they remain operational and continue to provide a high level of care to residents, Petersen attorney Dan McGuire said at the company’s first court appearance since filing for bankruptcy Wednesday in Wilmington, Delaware. (Knauth, 3/22)


The Wall Street Journal:
Masimo To Separate Consumer Business


Masimo will look to separate its baby monitor and smart watch businesses, months after the company won its years-long expensive legal battle against Apple over certain features in its watches. The Irvine, Calif.-based medical technology company said Friday that its board had authorized management to evaluate a proposed separation of its consumer business. Masimo expects the separation to include its consumer audio and consumer health products. (Glickman, 3/22)


AP:
Using Public Funds Or Facilities For Gender-Affirming Care Banned By GOP-Led Idaho Legislature


The GOP-led Idaho Legislature has passed a bill that would ban the use of any public funds for gender-affirming care, including for state employees using work health insurance and for adults covered by Medicaid. The Senate overwhelmingly approved the measure Friday after it previously passed through the House. It will be sent to Republican Gov. Brad Little’s desk, where he is expected to sign it into law. The governor has said repeatedly he does not believe public funds should be used for gender-affirming care. (3/22)


AP:
Texas Medical Panel Won't Provide List Of Exceptions To Abortion Ban


A Texas medical panel on Friday rebuffed calls to list specific exceptions to one of the most restrictive abortions bans in the U.S., which physicians say is dangerously unclear and has forced women with serious pregnancy complications to leave the state. The head of the Texas Medical Board also said that wider issues surrounding the law — such as the lack of exceptions in cases of rape or incest — were beyond the authority of the 16-member panel, twelve of whom are men. Only one member of the board is an obstetrician and gynecologist. (Stengle, 3/22)


AP:
Republican Lawmaker Says Kentucky's Newly Passed Shield Bill Protects IVF Services


Kentucky legislation shielding doctors and other health providers from criminal liability was written broadly enough to apply to in vitro fertilization services, a Republican lawmaker said Friday as the bill won final passage. The measure, which now goes to Democratic Gov. Andy Beshear, would accomplish what other bills sought to do to safeguard access to IVF services, GOP state Sen. Whitney Westerfield said in an interview. (Schreiner, 3/22)


AP:
Wyoming Governor Vetoes Abortion Restrictions, Signs Transgender Medical Care Ban For Minors


Wyoming’s governor on Friday vetoed a bill that would have erected significant barriers to abortion, should it remain legal in the state, and signed legislation banning gender-affirming care for minors. The abortion bill rejected by Gov. Mark Gordon, a Republican, would have required facilities providing surgical abortions to be licensed as outpatient surgical centers, adding to their cost and the burdens they face to operate. (Gruver, 3/22)


This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.

Source link

The Detroit Pistons, and Ausar Thompson, received a shock this week when the rookie forward was diagnosed with a season-ending blood clot on Wednesday. 

The 2023 No. 5 overall pick had already missed five games prior to the announcement with what was initially characterized as “asthma.” Despite the gravity of the diagnosis, Thompson has already been cleared for conditioning work and is expected to return to non-contact basketball activities after the season’s conclusion on April 14. 

The Free Press spoke with Dr. Geoffrey Barnes, cardiologist and vascular medicine specialist at the University of Michigan Health Frankel Cardiovascular Center, about blood clots and how they impact professional athletes. Barnes is not involved in Thompson’s medical care, and the Pistons didn’t provide details on the exact nature of his clot. 

Most commonly, a blood clot diagnosis references a clot in the veins of the legs (a deep vein thrombosis, or DVT), or a blood clot that has broken free from the veins, traveled up through the body and lodged itself into the lungs (a pulmonary embolism, or PE). 

HIGH HOPES: Why Pistons are optimistic after Ausar Thompson's scary blood clot diagnosis

The former is often accompanied with pain or swelling in one leg. Pulmonary embolisms impact the upper body — chest discomfort, shortness of breath, a sped-up heartbeat and potential lightheadedness and dizziness if it becomes more severe. 

“That’s usually what people mean when they say ‘Oh, they have blood clots,’" Barnes said. “It’s something in the vein system, starts in the legs, can break free and travel to the lungs. It’s incredibly common, over a million people every year in America get these. 

“They tend to happen most commonly in folks as they age, so it’s much more common in people over the age of 60 or 65 than in younger folks. They can happen for a wide range of reasons. But oftentimes they just come out of the blue and we can never figure out exactly why somebody developed their blood clot.” 

The severity of the symptoms, coupled with diagnostic testing, allows doctors to determine the severity of the clot, Barnes said. A small clot in the leg may be accompanied by mild swelling and soreness, and can be treated with blood thinners without the need for a hospital stay. 

On the extreme end, a large clot lodged into the lung could block blood flow and strain the heart — leading to a quickened heart rate and fast breathing due to a lack of oxygen. 

“That’s when people are in the hospital, we often have to do surgery or procedure to try and remove the blood clot and figure out ways to really support them through it,” he said. “It’s a really wide-ranging condition. Thankfully, the vast majority of people do very well and have more minor blood clots, the forms in the legs or a small one in the lungs that aren’t life-threatening.”

Outcomes have varied for NBA players recently diagnosed with blood clots. The most notable example is Hall of Famer Chris Bosh, whose career was ended prematurely by clots. He was ruled out for the remainder of the 2014-15 season in late February after a clot was discovered in one of his lungs. 

Bosh, a two-time NBA champ with the Miami Heat, reportedly felt pain in his back and side for several days before getting his symptoms checked out. He returned for Miami’s season opener in 2015-16, but a blood clot in his leg shut him down for the final time the following February. The NBA eventually ruled continued clotting issues were a career-ending illness. 

Other players, such as New Orleans Pelicans forward Brandon Ingram, have been able to resume their careers without further issues. 

The good news, Barnes said, is that most professional athletes are low-risk due to their age. But there are factors, such as dehydration and longer-distance flights, that can increase the risk for athletes.

The main treatment for everyone who has a clot, regardless of athletic status, is to be put on a blood thinner. The medicine prevents new clots from forming, but also comes with an increased risk for bleeding. It’s often why athletes can’t play while they’re on thinners, he said. 

When athletes develop PEs, they work with doctors to make sure their heart and lungs sufficiently heal afterward. Symptoms such as chest discomfort and lightheadedness while walking are tracked. Physical activity can ramp up from there, starting with climbing stairs or going for a bike ride or jog. For DVTs, doctors check to see if pain and swelling have resolved. 

With that, athletes also go through cardiopulmonary exercise testing that allows them to measure heart and lung function. Recovery is quick for some — weeks to a couple of months. But it can take six months or more in extreme cases. In the worst cases, long term or permanent damage can prevent athletes from getting back to their prior status. It largely has to do with the size of the clot. 

Once a first clot happens, the risk of having a second one increases, Barnes said. But with minimized risk factors, many people are able to live the rest of their lives without a second complication. 

“The highest-risk people maybe have a genetic disorder that puts them at risk for blood clots,” he said. “Maybe they have cancer or another condition. Those are people who I get really concerned about. Some people have one blood clot and never have anything again the rest of their life, and don’t have other significant risk factors. 

“As you think about an athlete, it really depends on what kind of athlete and what kinds of activities that they’re doing. You could imagine that maybe a golfer or a billiard player, somebody who is a high-level athlete but doesn’t necessarily have that same level of cardiovascular strain might not be at quite as high a risk as somebody who, say, is a soccer player who’s having to run 10 miles every game and is having issues with dehydration and is flying all over the world. It depends on the situation for each athlete.”

Contact Omari Sankofa II at osankofa@freepress.com. Follow him @omarisankofa.



Source link

Snoring disrupts sleep not just for the sufferer but also for their partner. While a nighttime symphony of sniffles and snorts might seem minor, it could signal a more serious underlying condition: sleep apnea. This article delves beyond the disruptive sounds of snoring to explore the realities of sleep apnea, its potential health risks, and the importance of seeking timely treatment.


Understanding Sleep Apnea: More Than Just Snoring

Sleep apnea is a prevalent sleep disorder characterized by repeated pauses in breathing throughout the night. These pauses can last for seconds or even minutes, causing the brain to wake up to restart breathing briefly. Individuals with sleep apnea often experience frequent nighttime awakenings, even if they’re unaware of them, leading to fragmented sleep and daytime fatigue.

There are two main types of sleep apnea:

  • Obstructive sleep apnea (OSA) is the most common type, caused by a blockage of the airway during sleep. Relaxed throat muscles or enlarged tissues can obstruct the airway, leading to breathing pauses.
  • Central sleep apnea is less common when the brain fails to signal to breathing muscles.

Symptoms and Risks of Untreated Sleep Apnea

While loud snoring is a common symptom of sleep apnea, it’s not always present. Here are some other signs and symptoms to watch out for:


  • Excessive daytime sleepiness (EDS): Feeling constantly tired and struggling to stay awake during the day.
  • Witnessed apneas: A partner observing periods where your breathing stops and restarts.
  • Morning headaches: Waking up with a persistent headache upon arising.
  • Restless sleep: Experiencing frequent tossing and turning throughout the night.
  • Mood changes: Increased irritability, difficulty concentrating, or feeling depressed.

Untreated sleep apnea poses significant health risks. Here’s why seeking timely diagnosis and treatment is crucial:

  • Increased risk of heart disease: Sleep apnea can contribute to high blood pressure, irregular heartbeats, and an increased risk of heart attack and stroke.
  • Metabolic issues: Sleep apnea can disrupt hormones that regulate blood sugar, potentially leading to type 2 diabetes.
  • Cognitive decline: Fragmented sleep due to sleep apnea can impair memory, focus, and overall cognitive function.
  • Increased risk of accidents: Daytime sleepiness associated with sleep apnea can significantly increase the risk of accidents while driving or operating machinery.

Taking Action: Diagnosing and Treating Sleep Apnea

If you suspect you or your partner might have sleep apnea, it’s crucial to seek medical attention. Diagnosis typically involves a sleep study, in which you spend the night in a specialized facility monitored for breathing patterns, oxygen levels, and brain activity.

Here are some standard treatment options for sleep apnea:

  • Continuous positive airway pressure (CPAP): This is the most common treatment, utilizing a mask worn during sleep that delivers a constant stream of air to keep the airway open.
  • Oral appliance therapy: Sometimes, a custom-made mouthguard can be worn at night to help maintain an open airway.
  • Surgery: In severe cases, surgery might be necessary to remove or reshape tissues blocking the airway.

Prioritizing Sleep Health: A Sound Investment in Your Well-being

Sleep apnea is a treatable condition, but timely diagnosis and intervention are crucial. Ignoring the problem can have severe consequences for your overall health and well-being. Here are some key takeaways:

  • Don’t dismiss loud snoring: While not everyone who snores has sleep apnea, persistent snoring warrants a visit to your doctor.
  • Be aware of the symptoms: Daytime fatigue, frequent awakenings, and morning headaches could be signs of sleep apnea.
  • Seek professional diagnosis: A sleep study is the most effective way to diagnose sleep apnea and determine the appropriate treatment course.
  • Treatment improves quality of life: Addressing sleep apnea can significantly improve your sleep quality, energy levels, and overall health.

By prioritizing sleep health and seeking professional help if you suspect sleep apnea, you can reclaim restorative sleep, reduce your risk of chronic health problems, and improve your overall quality of life. Remember, a good night’s sleep is an investment in your well-being, and addressing sleep apnea is a critical step towards achieving a healthier, happier you.

This story was created using AI technology.



Source link

The objective of this event focused on providing information about the main diseases that afflict the female population, so that they can ensure their comprehensive well-being.

By: Maria Camila Sanchez

March 23, 2024

A new educational day focused on the health and well-being of women, led by the Medicine and Public Health Magazine, has successfully concluded this Saturday, March 23.

Starting at 10 in the morning, attendees gathered at the Plaza del Caribe shopping center in Ponce, where they were able to participate and attend important talks with speakers from different medical specialties, such as cardiology, research, dermatology, among others. others.

Cardiovascular health in women

According to medical literature, arrhythmias constitute one of the 4 cardiovascular diseases that most affect women worldwide, the most common of these being atrial fibrillation, characterized by chest pain, difficulty breathing, extreme fatigue, palpitations, low blood pressure, and dizziness.

When this condition is not treated properly, it can lead to health problems or associated complications, such as stroke or heart failure.

“We have to identify it,” emphasized Dr. Sharlene Medina, an interventional cardiologist. “We have to reduce the burden of this arrhythmia on the heart because it will cause changes in the heart, such as enlargement of the atria of the heart, heart failure and many conditions that we can avoid.”

Colorectal cancer in women

According to the National Cancer Institute, colon cancer is a highly treatable and often curable disease when located in the intestine. Its treatment consists of surgery, which allows 50% of patients to achieve complete remission.

In fact, stages 0 to III of this disease are those that can be cured through the procedure, hence the awareness of early detection of this condition.

“Early detection is extremely important to avoid reaching more advanced stages for which we do not have a cure as an option,” said Dr. Liza Vázquez, hematologist-oncologist at Hospital Damas de Ponce.

Endometriosis and its delay in diagnosis

Recent studies suggest that, globally, it takes up to 7 years for women to be diagnosed with endometriosisHowever, in Puerto Rico, this number increases to 9.

“Why isn’t menstrual pain a red flag of alarm, and doesn’t it indicate that women seek help?” asks Dr. Idhaliz Flores, researcher at Ponce Health Sciences University. “Could it be because it is related to the menstrual cycle? Could it be because there are so many taboos and stigmas associated with the menstrual cycle that we don’t talk about it? Menstrual pain that incapacitates you is not normal.”

If you want to know more about the presentations held during this event, don’t miss the special programming that we have prepared for you on the social networks of the Revista Medicina y Salud Pública (@revistamsp).



Source link

Hospital-At-Home Market to reach over USD 514.08 billion by the year 2031 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Hospital-At-Home Market Size, Share & Trends Analysis Report By Products (Therapeutic, Testing, Screening And Monitoring Products, And Mobility Care Products), Services (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy And Pregnancy Therapy) And Disease Indications (Cardiovascular Disorders & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Cancer, Wound Care )- Market Outlook And Industry Analysis 2031"

The Global Hospital-At-Home Market is estimated to reach over USD 514.08 billion by 2031, exhibiting a CAGR of 8.62% during the forecast period.

Get a free sample copy of the report: www.insightaceanalytic.com/request-sample/1776

Home healthcare refers to a variety of medical therapies offered to address a patient's condition or injury in the convenience of their own home. Countless options are available to patients who want to get home health care. Depending on each patient's situation, care might range from nursing to specialized medical treatments, such as laboratory workups. Due to declining birth rates and rising life expectancy, the world's population is aging quickly. This could lead to a high frequency of chronic diseases and increasing demand for home healthcare services and software. The elderly population is anticipated to significantly affect the market.

The market is anticipated to develop as a result of the aging population, rising incidence of targeted disorders such as Alzheimer's and memory loss, as well as orthopedic diseases. Politicians and health organizations are working to decrease healthcare expenditures since one of their top concerns is the rising cost of treatment. Healthcare provided at home is more affordable than a costly hospital stays.

In emerging nations, non-communicable illnesses are now more prevalent due to improvements in medicine. Sedentary habits and heavy alcohol use are the main causes of the rise in the prevalence of lifestyle diseases. The market is anticipated to be pushed by an increase in the incidence of long-term care-related target diseases such as dementia and Alzheimer's.

List of Prominent Players in the Hospital-At-Home Market:

• GE Healthcare

• 3M Healthcare

• A&D Company

• Abbott Laboratories

• Acelity L.P.

• Almost Family

• Amedisys

• Arkray, Inc.

• B. Braun Melsungen AG

• Baxter International Inc.

• BAYADA Home Health Care

• Becton, Dickinson And Company

• ConvaTec Group PLC

• F. Hoffmann-La Roche AG

• Fresenius Medical Care

• Hollister Inc.

• INVACARE CORPORATION

• Kindred Healthcare

• Kinnser Software

• LHC Group

• Linde Corporation

• McKesson Medical-Surgical Inc.

• Medline Industries, Inc.

• Medtronic PLC

• Molnlycke Health Care

• Omron Healthcare

• Philips Healthcare

• Portea Medical

• RESMED

• Roche Holding AG

Market Dynamics:

Drivers-

The prevalence of target diseases, like Alzheimer's and insanity and orthopedic diseases, is predicted to rise along with the aging population. Governments and health organizations are working to control healthcare expenses since one of their concerns is the rising cost of treatments. Healthcare provided at home is more affordable than using pricey medical facilities. The continued rise in elderly individuals will considerably support the market for home healthcare. This disposable household income mostly enables people to control healthcare spending. There is a constant increase in the demand for home healthcare services and home nursing care worldwide. The popularity of home healthcare is growing, and it is becoming a more popular choice due to factors like the high expense of hospital treatment, the convenience of recovering at home, and its affordability. These gadgets are also popular in economically developed and underdeveloped regions.

Challenges:

The main issue is a need for more knowledge about technological items in developing nations, which is expected to slow the expansion of the home healthcare market. However, the availability of experienced workers with specialized skills and the high cost of home healthcare items will likely impede the market's expansion in the upcoming years.

Regional Trends:

North America hospital-at-home dominates the market position. This nation is a market leader because of significant investment in the healthcare sector and top-notch physicians and nurses. The number of ambulatory surgery centers and the overall senior population in North America are rising at record rates, which spurs the use of the home healthcare system. Factors including the widespread use of advanced technologies, the incidence of chronic and lifestyle diseases, rising healthcare costs, physician shortages, and growing customer appetite for better healthcare services all contribute to North America's significant market share globally. Besides, Asia Pacific had a notable share of the market. The need for home healthcare goods and services is rising due to factors like underdeveloped infrastructure for healthcare, expensive in-hospital healthcare facilities, and chronic conditions that demand long-term care. Corporations are also putting more emphasis on underdeveloped nations like China and India.

Curious about this latest version of the report? @ www.insightaceanalytic.com/enquiry-before-buying/1776

Recent Developments:

• In May 2022, GE Healthcare has agreed to invest up to $50 million in the Israeli startup Pulsenmore, signaling another strategic step forward in enabling precision health. This investment aims to accelerate the global adoption of Pulsenmore's homecare ultrasound solutions and will support the company's pursuit of U.S. Food and Drug Administration clearance and commercial growth.

• In Oct 2021, Portea Medical has secured a $7.7 million local currency guarantee facility from the United States International Development Finance Corporation (DFC). The DFC-guaranteed loan will be used to support the rapid expansion of Portea Medical's business through digitalization, expansion of service offerings, geographic expansion, and the development of home healthcare delivery channels.

Segmentation of Hospital-At-Home Market-

By Product-

• Mobility care products

• Testing, Screening and Monitoring products

• Therapeutic

By Services

• Hospice & palliative care

• Infusion Therapy

• Pregnancy Therapy

• Rehabilitation Therapy

• Respiratory Therapy

• Skilled Nursing

• Unskilled Care

By Disease Indication-

• Cardiovascular Disorders & Hypertension

• Diabetes

• Respiratory Diseases

• Pregnancy

• Mobility Disorders

• Cancer

• Wound Care

• Other Indications

By Region-

North America-

• The US

• Canada

• Mexico

Europe-

• Germany

• The UK

• France

• Italy

• Spain

• Rest of Europe

Asia-Pacific-

• China

• Japan

• India

• South Korea

• Southeast Asia

• Rest of Asia Pacific

Latin America-

• Brazil

• Argentina

• Rest of Latin America

Middle East & Africa-

• GCC Countries

• South Africa

• Rest of Middle East and Africa

For More Customization @ www.insightaceanalytic.com/report/hospital-at-home-market/1776

Contact Us:

InsightAce Analytic Pvt. Ltd.

Tel.: +1 718 593 4405

Email: info@insightaceanalytic.com

Site Visit: www.insightaceanalytic.com

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.

Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Source link

Jake GyllenhaalShare on Pinterest
Jake Gyllenhaal shared in a recent interview that he got a staph infection after being cut by glass while filming his new movie ‘Road House.” Cindy Ord/Getty Images for SiriusXM
  • Actor Jake Gyllenhaal says he contracted a staph infection while filming a fight scene for Road House.
  • Staph infections occur when staphylococci bacteria enter the body via a cut or abrasion.
  • Staph infections can be mild, but they can also be serious and life-threatening.
  • You should see a physician immediately if you experience rapid heart rate, neck stiffness, chest pain, fever, severe headache, or trouble breathing.

Jake Gyllenhaal has revealed he contracted a staph infection while shooting his latest movie.

Chatting on Dax Shephard’s Armchair Expert podcast alongside his co-star Conor McGregor, Gyllenhaal shared that while filming a fight scene for Road House, he cut his hand, and it resulted in a staph infection.

Recalling the scene, he said: “We’re fighting on the floor, fighting around tables, we’re fighting around glass.”

During the scene, the actor sustained an injury when he placed his hand on glass. “I felt the glass going in my hand. I remember the feeling [and] went, ‘That’s a lot of glass,” he shared.

Gyllenhaal hurt himself while filming another portion of the film. “I thought [the infection] came from, remember that scene where you come with a piece of wood?” he asked McGregor.

“I grabbed your arm, and I thought, ‘Oh, maybe I’m injured.’ But my whole arm swelled up. It ended up being staph.”

Staph infections are common, and in some cases, they can be serious. However, there are steps you can take to reduce your risk of infection following an injury.

“All of us have staphylococci bacteria and other bacteria on our skin. This is normal and healthy and part of our microbiome,” explains Daniel D. Rhoads, vice chair of the College of American Pathologists Microbiology Committee.

“What can become a problem is when the skin’s integrity is compromised, and the bacteria that are normally on the surface of our skin can now contaminate deeper tissue where bacteria do not belong.”

Sometimes this compromise in the skin can be imperceivable, like a minor cut or small abrasion that you do not even notice. Other times, the compromise is more obvious, as it was for Gyllenhaal.

Either way, Rhoads says, when we have a cut or abrasion, there is always a risk that bacteria from our skin (in this case, Staphylococcus aureus, also known as S. aureus) or from the environment could not only contaminate the exposed tissue but could also start growing.

This is a staph infection, and it triggers the body’s immune response, resulting in calor, dolor, rubor, and tumor.

“Mr. Gyllenhaal described his arm swelling up. That swelling is “tumor.” I would bet that his arm was also red (rubor), hot (calor), and painful (dolor),” Rhoads explains.

Staph infections can range in severity. When a bacterial infection like this starts spreading from the local site of the tissue damage toward the middle of the body, Rhoads says it’s “bad news” because it means the immune system is having a hard time curtailing the infection.

Dr. Linda Yancey, infectious disease specialist at Memorial Hermann Health System in Houston has a helpful analogy in understanding the varying degrees of infection.

“To say “Staph infection” is like saying “traffic accident.” They range from fender benders to sixteen-car pileups and everything in between,” she explains.

“Most Staph infections are minor and resolve on their own, but the more severe ones require medical care.”

Staph infections on the mild end of the spectrum will usually present with a little pain and swelling. Often, the immune system is able to fend off the infection, and it will go away without medical or surgical intervention.

However, that’s not always the case. “Staph infections are most concerning when they are spreading quickly, and symptoms transition from local tissue inflammation to systemic symptoms, for example, chills and increased rate of breathing,” Rhoads warns.

In the most extreme cases, which were much more common before we had antibiotics, Rhoads says severe local infections can spread to cause a systemic infection and then death.

It can be challenging to prevent staph infections, given that the bacteria that causes them is already present on the skin. However, Yancey says good hygiene is the cornerstone of good health.

It’s important to regularly – and thoroughly – wash your hands. You should also shower after physical activity. These steps can keep cuts clean and reduce the risk of infection.

Rhoads says, “It’s good to wash cuts and abrasions with soap and water to try to remove bacteria and debris that could be contaminating a new wound.”

You should also keep any open wounds covered to stop bacteria from entering the skin.

Meanwhile, sharing towels, razors, and other pieces of personal equipment, such as makeup brushes, is a big no-no.

“People who share sports equipment, for example football teams, should ensure that equipment is cleaned and sanitized between uses,” Yancey adds. The same rings true if you exercise in a public place, like a gym.

If you are concerned about a staph infection, Yancey says your first step should be your primary care provider.

“However, if the infection you are concerned about is a boil or abscess, urgent care or an emergency room is a better choice as they will have the equipment to drain it if needed.”

It’s essential you seek medical assistance if you notice the infection is getting worse and is spreading quickly or if it’s accompanied by fever, headache, neck stiffness, and/or chest pain, rapid heart, and trouble breathing.

Oftentimes, staph infections can be treated with antibiotics, though sometimes surgery may be required.

Staph infections happen when bacteria enter the body via a cut or abrasion. They can be mild and clear up on their own.

However, staph infections can also be serious and life threatening. If you’re concerned, you should consult a medical professional straight away.

Source link

"My name is George Irungu and I am 37 years old. I am a pharmaceutical technician at North Kinangop Catholic Hospital in Nyandarua County.

I have battled tuberculosis three times. I was first diagnosed with pulmonary tuberculosis in 2005 when I was in secondary school. I started treatment in August 2005 and finished after six months. I was tested and found to be free of TB. However, due to remnants of previous infections, I contracted the disease again in 2022.

My symptoms were a persistent cough that lasted for a month, night sweats, fever, general weakness and loss of appetite.

At first, I was in doubt. I was tested again and the diagnosis was confirmed. I was given the standard six-month course of TB medication. After finishing the medication, I was tested to confirm that I was free of TB. Six months later the symptoms came back. The TB test was negative, but the cough would not go away.

I was so scared. I remember sweating profusely on my bed. I would wake up every morning to sheets soaked with sweat. I lost weight every day. I remember that I weighed 64 kilos before I got sick, but when TB recurred, I dropped to 50 kilos. 

There was that fear of infecting my children and my colleagues at work. My contacts were screened and tested and they went for X-rays and they were found to be negative for TB infections. 

A Computed Tomography (CT) Scan was conducted and showed that my lungs had cavitation, small holes in the lungs. Further tests were conducted and I underwent a lobectomy, a surgery to remove one of the lobes of the lungs. 

The infected lobe was removed to prevent the infections from spreading to the other lobes. There were still remnants of TB bacteria in my lungs and I had to restart the treatment again because it was not clear whether the remaining parts of my lungs were clear of the TB. Now this was the third time.

The lungs have sections called lobes. The right lung has 3 lobes. The left lung has 2 lobes. A lobectomy may be done when a problem is found in just part of a lung.

After undergoing lobectomy, my journey towards recovery was a difficult one. After a piece of my lungs was removed, breathing became difficult for several months. I used to exercise a lot to improve my general health.

So far, I have experienced full recovery. I can run, swim and I can properly function post TB treatment. 

When I contracted TB in 2005, I was in denial, which I attribute partly to the stigma associated with the disease. 

My family got worried when they learnt I had TB. They thought it was a bad disease which was untreatable. Some people associate the condition with other diseases like HIV/Aids or sexually transmitted infections. Others insinuated that I was cursed.

My aunt told me, "oooh you have TB? That's a very bad disease. Ooh noo." 

I urge members of the public to go for TB screening in the nearest health facilities and for those on TB treatment to complete medication so as to get cured. 

I would also like to urge my fellow health workers to go for routine TB screening as well as actively screen patients when they visit the facility.”

Tuberculosis is caused by a bacterium called Mycobacterium tuberculosis. Kenya is among 30 high TB burden countries in the world.

Pulmonary tuberculosis affecting the lungs, is the commonest form of TB causing a distinctive cough. Apart from Pulmonary tuberculosis, the bacteria can also cause TB of the bladder, spine, skin, brain and even the heart. But there are types of TB in which individuals don’t experience such symptoms that is; latent TB. In this case, one’s immune system fights the bacteria and the disease is not transmissible.

On January 21, the Ministry of Health National TB Programme in collaboration with Centre for Health Solutions-Kenya through its USAID-funded Tuberculosis Accelerated Response and Care II (TB ARC II) and other partners launched a plan to combat tuberculosis in Kenya.

The plan, dubbed National Strategic Plan for Tuberculosis, Leprosy and Lung Health is a five-year (2024-28) strategic plan that aims to ensure quality care for TB, leprosy and lung diseases for all Kenyans.

Public Health and Professional Standards Principal Secretary Mary Muthoni raised concern about what she termed as the scourge that is TB. The PS said that the ministry is committed to further reducing the cases of TB reported in a year by 2030. 

In 2022, Kenya reported a total of 90,841 TB cases, an increase compared to the 77,854 cases reported in 2021. In the same year, 17,000 people died of TB. 

Kenya recorded a 32 percent decline in TB incidence and a 42 percent mortality reduction between 2015-2020. 

“Alarming as this figure is, it represents only 68 percent of the estimated 133,000 TB cases that were likely to emerge that year, leaving 32 percent undiagnosed and untreated,” the PS said.

However, Muthoni regretted the emergence of drug-resistant TB cases, totaling 756 cases last year, which highlights the urgent need for a comprehensive and coordinated response. 

“The strategic plan does not only acknowledge the existing challenges in TB control but also proposes practical interventions to address the root causes of these barriers,” she said, identifying partnership and accountability as the key pillars towards a united front in this battle. 

An estimated 10.6 million people fell ill with TB across the globe, including 5.8 million men, 3.5 million women and 1.3 million children according to the World Health Organisation. 

Source link

While exploring bariatric surgery for weight loss in 2008, Monica Rosco of Medina, Ohio, was diagnosed with obstructive sleep apnea.

“My insurance at the time said that to qualify for the surgery, one of the criteria I would need to show was a comorbidity,” she says. “I hadn’t even thought about the possibility of having sleep apnea.”

Sleep apnea, a condition in which breathing repeatedly stops and starts, can lead to cardiovascular disease, stroke and other health issues. “When they did an assessment, followed by a sleep study, they had to throw a CPAP (continuous positive airway pressure) mask on me right away,” she says.

Monica began using a CPAP machine every night. “It scared me to think about all of the health issues I could have had without it,” she says. “I was only 38.”

After having bariatric surgery in 2009, she thought it would be all right to stop using CPAP, which she did for a few years. “Then, I gained back some weight, and my husband said, ‘You’re snoring all the time.’ He’s a very light sleeper, and so it was a problem for him. I would have ignored it otherwise, as it wasn’t bothering me. But I was having some episodes where I woke up gasping. I had another sleep study, and they said, ‘You need to use CPAP.”

Monica struggled over the years with a variety of CPAP masks, unable to find a comfortable fit. In addition, “the pressure was too high on my machine,” she says. “But this was during the Covid pandemic, and people could not get new machines.”

In 2022, she learned of an implanted device called Inspire® that would allow her to breathe and sleep through the night without CPAP. The FDA-approved device delivers upper airway stimulation that is synchronized to a person’s breathing to relieve obstruction during sleep. It is an alternative option for patients who have not had success with CPAP and are good candidates for the implant.

Monica Rosco with her husband.
Monica Rosco celebrated her 50th birthday with her husband John on a Carribbean cruise to Mexico.

She went for an evaluation with Alan Kominsky, MD, FACS, a sleep surgeon in Cleveland Clinic’s Department of Otolaryngology - Head and Neck Surgery. “People who are intolerant of CPAP can’t wear it for a whole variety of reasons. They can’t keep it on, they feel claustrophobic, etc.,” Dr. Kominsky says. “Patients who fall into certain categories with weight and anatomy can be candidates for Inspire therapy, which is like a pacemaker for the tongue.”

Monica was deemed to be a good candidate, which led to further assessment. “We look at how severe the sleep apnea is and their sleep patterns to determine whether it’s appropriate to examine them by using sleep endoscopy,” Dr. Kominsky says.

Endoscopy entails light sedation in an operating room at a level that allows the patient to breathe unassisted, mimicking sleep. A small telescope is placed inside the patient’s nose to visualize the soft palate and airway. “They have to collapse in a certain way, in a flat fashion, not curved and circular, for the device to work properly,” Dr. Kominsky says. “Approximately 90 percent of those selected for endoscopy will qualify for the implant.”

Once it is determined that the patient meets the criteria, the device is implanted during an outpatient procedure, under general anesthesia. “It requires two incisions, one in the upper neck by the jaw, which allows us to find the specific part of the nerve that goes to the tongue and makes it move,” Dr. Kominsky says. “We put an electric stimulation cuff around it. The other incision is in the upper chest, where we place the device and a sensor between the ribs, and then it’s all connected. The patient goes home, usually without the need for pain medication, and heals for a month. Then, we refer the patient to Brian Chen, MD, and his colleagues in Cleveland Clinic’s Sleep Disorders Center to activate and adjust it.”

When the device has been activated, the patient uses remote control to turn it on at night before going to sleep. From that point, treatment becomes automatic. “Each breath stiffens the tongue and opens an airway behind the tongue,” Dr. Kominsky says.

“It’s a strange feeling until you get used to it,” Monica says. “Once the device is turned on, the back of my throat collapses as my tongue muscle is forced forward and the airway opens. The higher the setting, the more forceful the muscle contraction. But when I’m asleep, I don’t feel it.”

In his experience, Dr. Chen says, patients like Monica, who have moderate to severe sleep apnea, are “very happy with their treatment.” He follows up with them every six weeks after the procedure until his patients are comfortably treating their sleep apnea, and every six months thereafter. 

“There is less maintenance on their part than with CPAP,” he says. “In addition, the newest batteries for the device now last 11 years, and with suggestions from patients and practitioners, Inspire is always making scientific advancements.”  

Monica says she is happy that she had the procedure, which has improved her personal relationships and her work life as a clerical manager at Cleveland Clinic. “I feel like I was crankier before and didn’t manage my stress as well. I feel better in general, healthier, with more energy. I am a heavier sleeper now, with more dreaming. I can feel the change.”

And there are additional benefits. “For our 25th wedding anniversary in the fall, we went to Europe for two weeks. It was so amazing not to have to travel with a CPAP, which I used to make my husband carry. I just put my device remote in my carry-on bag and could turn it on during the flight.

“Not dealing with a mask anymore has been the best part. It’s well over a year, and every night, I’m thankful.”


Related Institutes:
Head & Neck Institute,
Neurological Institute

Source link

In 2024, pulmonary rehabilitation turned 50.1 Yet even after being around for half a century and documenting consistent improvements in patient outcomes, pulmonary rehabilitation “remains underused and underresourced,” according to the 2023 American Thoracic Society (ATS) clinical guidelines for pulmonary rehabilitation.2

Pulmonary rehabilitation “reduces dyspnea; increases exercise capacity; improves health-related quality of life (HRQoL) and emotional function; confers social support; and, for those with chronic obstructive pulmonary disease (COPD), reduces hospital admissions and mortality risk after hospitalization,” according to the ATS guidelines.2

“Pulmonary rehabilitation (PR) is an essential component of the integrated care of people with chronic respiratory disease,” said ATS guideline authors, who went on to offer recommendations on when pulmonary rehabilitation should be used, based on evidence showing that PR led to improved patient outcomes. The guidelines recommend offering2:

  • pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD) and for adults following hospitalization for COPD exacerbation (strong recommendations);
  • center-based pulmonary rehabilitation or telerehabilitation for chronic respiratory disease (strong recommendation);
  • pulmonary rehabilitation for patients with interstitial lung disease (strong recommendation);
  • either supervised maintenance pulmonary rehabilitation or usual care after initial pulmonary rehabilitation for adults with COPD (conditional recommendation); and
  • pulmonary rehabilitation for patients with pulmonary hypertension (conditional recommendation).

You can’t do pulmonology and ICU medicine without RTs…It’s good to be hand in hand with RTs, especially when you’re dealing with respiratory problems. In the ICU world, that might mean assisting with ventilator management, oxygen delivery, bilevel positive airway pressure, and treatments like that.

Respiratory therapists (RTs) are among the health care providers who offer pulmonary rehabilitation to patients. These specially trained health care providers can bridge gaps between patients and pulmonologists and improve care in a health care system that’s stretched beyond its limits.

How can RTs and pulmonary/critical care physicians best work together? An example of the kind of effective teamwork that makes for better patient outcomes can be found at Temple Lung Center in Philadelphia, where such teamwork is encouraged. To gain insight into the role and value of RTs in improving patients care, we spoke with Temple Health pulmonologist Lijo C. Illipparambil, MD, who is also an assistant professor of clinical thoracic medicine and surgery at Temple’s Lewis Katz School of Medicine, and Temple respiratory therapist Noel Rice-Ham.

RT/Physician Collaboration at Temple Lung Center

All patients with pulmonary problems can benefit from RT, said Dr Illipparambil. Patients that benefit the most are those with chronic ventilator needs or chronic or advanced lung diseases, who require additional assistance due to their respiratory status, he added.

“Success stories are most often with chronic ventilator patients who an RT has worked with before or knows them very well. When you come on as a new attending or new team taking care of that patient, and you try to make changes or adjustments, the RT already knows the lung physiology and the mechanics of what works for that patient, so it can be very helpful to discuss [this] with the RT before you make any changes,” he shared.

At Temple Lung Center, pulmonologists and RTs work together in a system that fosters referrals and collaboration. From the physician point of view, RTs are generally very accessible, said Dr Illipparambil. “They’re very much integrated with us, and we work with them almost every day, both on the pulmonology and ICU side.”

“You can’t do pulmonology and ICU medicine without RTs,” said Dr Illipparambil. “It’s good to be hand in hand with RTs, especially when you’re dealing with respiratory problems. In the ICU world, that might mean assisting with ventilator management, oxygen delivery, bilevel positive airway pressure , and treatments like that.”

Pulmonologists at Temple meet with RTs every morning to discuss which patients will be extubated and to review the results of spontaneous breathing trials. “An RT is always there to help out with getting patients on other devices like HiFlo or BiPAP or even helping with clearance,” Dr Illipparambil noted. In pulmonology, RTs help with testing to identify diseases and get patients on the appropriate devices or pressure settings.

RTs also have a lot of experience with different settings and different machines like cough assist, which can help the patient clear mucus and feel better, noted Dr Illipparambil.

Rice-Ham said she works with a lot of patients undergoing lung transplantation at Temple. “I came from working inpatient, where I’d see patients right after transplants or in the ICU setting. Now, I see patients who come in regularly for testing prior to or after the transplant.”

How RTs Benefit the Patient Care Team

As a respiratory therapist, Rice-Ham knows from experience that RTs often remember patients from past visits and may spend substantial time watching how patients react to different treatments in critical and noncritical settings. “I get to know the patients from the inside out and observe how they’re progressing. Physicians rely on us to see the things they don’t always see,” she said.

In her current position, Rice-Ham estimated that she spends an equal amount of time doing testing and speaking to patients. “We find ourselves having personal talks with patients and families, especially in the outpatient setting. Education can be as simple as discussing how someone wears their oxygen tank or cleans their equipment. We’re always prepared for whatever question comes up. Many patients want to know about using inhalers properly,” she explained.

Although 75% of RTs are employed by a hospital, studies highlight the advantages of RTs in community settings as well.3 As part of a multidisciplinary team, RTs can help identify the early stages of diseases like COPD by reviewing lung function and other risk factors, like social determinants of health. Earlier interventions and care can shift the health care system into a more preventative versus reactive mode, ultimately resulting in cost savings and improvements in patients’ quality of life.

While physicians like Dr Illipparambil consider RTs to be a vital part of the patient care team, Rice-Ham said that some collaborative barriers remain, particularly in the inpatient setting. “At the lung center, we see a lot of patients. In the inpatient setting, it’s not as often. I don’t know if the inpatient physicians include us as much as they could. It depends on the physician’s experience with RTs,” she explained.

Why Is Pulmonary Rehabilitation Underutilized?

Although PR was originally developed for patients with COPD, its scope has expanded to address the needs of patients with other chronic respiratory diseases as well as those with cancer and undergoing lung transplantation.2

Yet, as the ATS pulmonary rehabilitation guidelines acknowledge, PR is underutilized. “Less than 5% of people with COPD who may benefit from PR receive it,” the ATS guideline authors noted.2 

The availability of these services is not the only problem, said the guideline authors; another reason for underuse of PR is “insufficient HCP [health care provider] and patient knowledge and awareness of the process and benefits of PR” and the fact that “HCPs’ referral of patients to PR is suboptimal.”2

“There needs to be more recognition of what a respiratory therapist is,” said Rice-Ham. “A lot of times, we don’t get that respect because other providers don’t know about our qualifications and training. There’s a barrier of the unknown about who we are.”

In some places, there are “respiratory-therapist-driven protocols” for patient care, she noted. Where such protocols exist, they help facilitate better relationships between RTs and physicians.

Another barrier to collaboration between physicians and RTs can be inadequate communication among busy health care professionals. Because RTs see so many patients, they need to know the plan for the day, especially if there are changes to a patient’s settings or recommendations. Physicians, nurses, and RTs must communicate and ensure everyone is on the same page.

The RT’s Evolving Role

Traditionally, respiratory therapists were thought of as technicians rather than practitioners, but their role has since evolved, said Rice-Ham, who has a bachelor of science degree in respiratory therapy as well as a master’s degree in health care administration.

RTs who conduct pulmonary rehabilitation are trained clinicians who can support patients with a range of pulmonary issues. Typical duties of an RT include analyzing blood and sputum in the lab, helping physicians diagnose lung and breathing disorders, assisting with the development of treatment plans, managing breathing equipment and devices, and providing education to patients and families.

Over the past several years, the RT’s role has evolved to meet the growing demands of patients beyond the critical care setting.3 In addition to specializing in critical care and pulmonary rehabilitation, RTs may also specialize in polysomnography, geriatrics, home care, pediatrics, or neonatal care.

RTs can start working with an associate’s degree, although many programs expect therapists to have a bachelor’s degree. RTs take boards similar to nursing, and many obtain specialty certifications in a particular area of expertise, said Rice-Ham. Every state besides Alaska also requires RTs to have a license to practice,4 and RTs must also undergo continuing education and renew their certification every 5 years.5

Some physicians, particularly in smaller community settings, may be unaware of the education and training required to become an RT, said Rice-Ham. Notably, this is not the case at Temple Lung Center, she added, where physicians have a high level of experience working with RTs and can see their capabilities firsthand.

The Future of Respiratory Therapy

The occupation of respiratory therapy is projected to grow by 13% to 23% over the next decade, outpacing many other professions.4,5 This increase is timely, as the Association of American Medical Colleges predicts the US physician shortage will reach 140,000 unfilled roles by 2033.6

In addition, respiratory therapy is among the many allied health professions that are expanding their advanced practice certifications to support rising patient demands. An Advanced Practice Respiratory Therapist (APRT) accreditation became available in June 2022. To complete the program, registered RTs must complete a graduate-level education and training program approved by the Commission on Accreditation for Respiratory Care.7

APRTs will practice as part of a physician-led team to document medical histories and progress noted and examine, treat, and educate patients. They’ll also order and interpret labs and diagnostic tests, reducing administrative work for physicians and enabling more efficient and hands-on care. As RTs and physicians continue joining forces, patients will undoubtedly benefit.

Source link

Bursting into song can make you feel good even if you are not blessed with the best singing voice. I am all but tone deaf yet have recently joined a ‘tuneless choir’, the premise of which is to sing as though no one is listening. 

The joy that comes with belting out the lyrics of your favourite song is unrivalled.

Community choirs are booming across Ireland with a 2022 study by the music therapy department at the University of Limerick showing that, for many, singing is a feel-good hobby.

The UL research team identified 185 groups singing for health and wellbeing, attracting people who would not normally believe their voice is tuneful enough for public performance, where no one is excluded from the swell of enthusiasm for song.

The study reported that social and communal singing can improve social connections and respiratory health, boost cognitive function, enhance mental health, reduce stress, and bring greater happiness.

Singing is a great stress-buster

Belting out a song can have a remarkable effect on stress levels, according to a study published in the journal Frontiers in Psychology. 

Provided you are singing in an environment that doesn’t make you feel anxious, singing was shown to reduce levels of the stress hormone cortisol.

Neuroscientists at Western Michigan University also showed that singing boosts levels of the feelgood hormone oxytocin.

Dr Julie Christensen, a neuroscientist in the Department of Psychology at the City University of London, says, “Music and singing are an enormous stimulation for our brains. Countless studies have shown that it impacts our hormonal balance and decreases stress more effectively than any medication.”

Singing helps to slow age-related cognitive decline

Joining a choir could lead to better brain health in older age, according to a study published in the International Journal of Geriatric Psychiatry earlier this year. 

The researchers found music and regular singing were linked to better brain health through improving memory and the ability to solve complex tasks. Also, continuing to sing later in life brings even greater benefits.

“Overall, we think that being musical could be a way of harnessing the brain’s agility and resilience, known as cognitive reserve,” said lead author Anne Corbett, professor of dementia research at Exeter University.

“Our findings indicate that promoting musical education would be a valuable part of public health initiatives to promote a protective lifestyle for brain health, as would encouraging older adults to return to music in later life.”

Singing can stop you snoring and help you sleep

Singing helps to strengthen the throat muscles which, in turn, can reduce snoring even in people diagnosed with obstructive sleep apnoea (OSA). 

Weak muscles in the soft palate of the mouth and the upper throat are a common underlying cause of chronic snoring and OSA. 

But specialists reporting in the International Journal of Otolaryngology and Head & Neck Surgery showed that 20 minutes of singing exercises performed daily for three months helped to strengthen these muscles, reducing the frequency and severity of snoring, and improving quality of sleep compared to those who didn’t sing.

Singing relieves anxiety and depression

Social singing, as part of a choir or a community singing group, helps to alleviate low mood, partly by promoting a feeling of belonging, security and wellbeing, according to researchers reporting in the BMJ

The team interviewed participants to find out if joining a singing group for six months had an effect on the mental health of participants, some of whom had been diagnosed with anxiety or depression. 

Their findings revealed that the social singing experience was “a lifesaver” for some. 

The researchers concluded that most people considered it “a key component” — and for some, the only component — in their recovery and ongoing psychological stability.

Singing is the new yoga

If you sing in a choir, your heartbeat will be synchronised with that of other members, rising and falling in time with the tempo of the music. 

And, as your exhale occurs during song phrases and inhale between them, singing is also a form of controlled breathing which researchers reporting in the journal Frontiers in Neuroscience suggest has the same benefits as breathing exercises in yoga. 

These effects were shown to “impose” a calm and regular breathing pattern that positively impacts heart rate and general health.

Singing could boost immunity

If you want to boost your immune system and help ward off illness, try singing along to favourite tunes rather than just listening to them.

German researchers from the Johann Wolfgang Goethe University asked participants to sing or listen to music. 

Listening to music lowered stress hormones such as cortisol, but when they sang the benefits were even greater, with raised levels of immunoglobulin A, an antibody that fights off infection.

In another study of cancer patients, researchers found that singing in a choir for just one hour a week led to increases in levels of cytokines. These immune system proteins help the body to fight serious illness.

Source link